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THE ROLE OF MERLIN AND APICOBASAL POLARITY IN ENDOMETRIAL 
DEVELOPMENT AND HOMEOSTASIS 
Abstract 
Erin Williams Lopez, B.A. 
 
Advisory Professor: Andrew B. Gladden, Ph.D. 
 
 
Apicobasal polarity and cell adhesion are necessary for the proper formation 
and organization of epithelial tissues. Merlin couples cell polarity and adhesion 
through correct localization of the polarity protein Par3 and maturation of apical 
junctions. Merlin and Par3 are necessary for the development and homeostasis of 
highly regenerative tissues like the epidermis. The continual repopulation of the 
endometrium after each menstrual cycle requires a constant reorganization of cell 
polarity and adhesion. The endometrium consists of a luminal epithelium that 
postnatally gives rise to the distinct glandular epithelium. Endometrial glands are 
necessary to secrete nutrients for the pre-implantation embryo. In addition, the 
endometrial gland is thought to be where endometrial cancer originates. While the 
endometrium is important for female fertility, relatively little is understood about how 
glands develop or how endometrial cancer forms. We examine the role of Merlin and 
apicobasal polarity in endometrial development and homeostasis. We determine that 
Merlin regulation of apicobasal polarity is necessary for proper endometrial gland 
formation. Apicobasal polarity is disrupted in low-grade endometrial cancer and 
mediates Notch regulated proliferation and migration in endometrial cancer cells. 
This dissertation reveals a critical role for Merlin and cell polarity in endometrial 
gland development, mammalian fertility, and endometrial cancer.  
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Chapter 1: Introduction 
 
1.1 Female Reproductive Tract Development 
The Female Reproductive Tract (FRT) consists of the vagina, cervix, 
uterus, oviducts, and ovaries(1). The FRT originates from the intermediate 
mesoderm which differentiates into the urogenital system,(2) containing the 
kidneys, urinary system, and FRT in females. The embryonic mesoderm 
proliferates and goes through a cell fate change creating two epithelial tubes, the 
Wolffian duct and the Mullerian duct. The Wolffian duct initially forms transient 
segments that eventually create one continuous tube. The Mullerian duct is 
formed when mesonephric epithelial cells invaginate and lengthen adjacent to 
the Wolffian duct. FRT development requires Wnt-mediated signals stimulated by 
the Wnt4, Wnt5a, and Wnt9b ligands to regulate Mullerian duct formation and 
elongation(3–5). 
The symmetric Mullerian ducts fuse after elongation, forming the complete 
FRT (Figure 1a). Mammalian species differ in the degree of fusion, generating 
different types of uteri with duplex, bipartite, or simplex forms (Figure 1b). A 
duplex uterus, observed in monotremes and marsupials, results when the uterine 
horns never fuse and each has an individual cervix. Duplex uteri are split into 
three sub-categories: without a vagina, with two lateral vaginae and central birth 
canal, or with a single vagina. Mice have a bipartite uterus (sometimes described 
as a bicornuate uterus) that has two separate   
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Figure 1 Development of the Uterus. 
The Mullerian duct (red line) migrates adjacent to the Wolffian duct (blue line) to form the 
primordial FRT(a, i-v). Once the Mullerian duct is fully formed, the Wolffian duct will 
begin to disintegrate in genetic females (a, v-vii). During disintegration of the Wolffian 
duct, the Mullerian duct will also differentiate into the Female reproductive tract (FRT) (a, 
vii-x). There are three types of FRT: (i) duplex, (ii) bipartite, and (iii) simplex. There are 
three subcategories of duplex FRTs do not have a vagina, have two vaginae, and one 
that has one vagina. There are a wide variety of bipartite FRTs including the two 
examples provided. Both exhibit two uterine horns with varying levels of connection and 
one cervix. A simplex FRT has two oviducts that connect to a single uterus (b). A 
diagram of a uterus cross-section (c). The outer layers of the uterus include two different 
myometrial layers. The innermost layer is the luminal epithelium with glandular 
epithelium strewn throughout the endometrial stroma surrounding the luminal epithelium 
(c). Endometrial gland development does not begin in most mammals until after birth (d). 
The luminal epithelium of the endometrium (tan) will begin to bud (i) off the main lumen 
(green). These buds will (ii) form teardrops, (iii) create elongated tubules, (iv) and 
eventually form sinuous and branched tubules. After puberty, the tubules will form an 
extensive secondary branching off the main glandular trunk (d).  
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uterine horns connected by a central cervix. In some species with a bipartite 
uterus, the uterine body is fused but still exhibits separate horns (Figure 1b). 
Finally, a few bat species and some primates like the human have a simplex 
uterus where the fusion of the Mullerian duct is more extensive, creating one 
central uterus with two separate oviducts and ovaries. Mice are commonly 
utilized to investigate mammalian FRT development, as it closely represents 
human FRT development(6, 7).   
Following the completion of Mullerian duct fusion, the Wolffian duct will 
regress in females (Figure 1a, blue). The differentiation of the Mullerian duct is 
driven by both repression or absence of signals like androgens and the activation 
of other signals like COUP-TFII (COUP transcription factor 2)(8). Mullerian 
differentiation leads to the formation of the oviduct, uterus, cervix, and upper 
vagina. This differentiation is regulated by a large number of proteins including 
multiple homeodomain transcription factors (Hox). There are specific Hox genes 
that pattern the different regions of the FRT. Hoxa9 is expressed during oviduct 
formation, Hoxa10 and Hoxa11 are required for uterine differentiation, and 
Hoxa13 promotes cervical and vaginal differentiation(9).  Disruption of the Hox 
patterning, by loss of Hoxa10 and Hoxa11 in mice, for example, causes a portion 
of the uterus to differentiate into oviduct(10). Similarly, Hoxa13 loss in mice 
causes the cervix to differentiate into uterus(11). Interestingly, in addition to 
development driven by Hox expression, the Wnt ligand, Wnt7a, also causes 
aberrant differentiation of the oviduct into uterus and the uterus into vagina(12).  
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The differentiation of the fused Mullerian duct structure results in numerous, 
morphologically diverse tissues. The upper vagina has a stratified squamous 
epithelium surrounded by a double layer of smooth muscle. The cervix has two 
distinct areas. One has a stratified squamous epithelium that is encased in a 
stromal layer, while the other area is a folded simple columnar epithelium that 
creates mucosal glands. The oviducts have three different portions: the 
infundibulum (close to the ovary), the ampulla, and the isthmus (closest to the 
uterus). The infundibulum actively helps move the egg released from the ovary 
into the oviduct. The ampulla is commonly where an egg is fertilized. The isthmus 
is a small portion of the oviduct that is connected to the uterus. The uterus is 
made up of the exterior layer, perimetrium, the myometrium, and the 
endometrium, the innermost layer (Figure 1c). The perimetrium is a thin 
membrane with a layer of connective tissue underneath that is the exterior of the 
uterus. The myometrium, derived from the Mullerian duct mesenchyme, is 
divided into two histologically distinct sets of smooth muscle (Figure 1c). The 
longitudinal myometrium is the outermost layer, while the radial myometrium is 
the inner layer. The endometrium consists of stroma, vasculature, and a simple 
columnar epithelium. The simple columnar epithelium develops after birth into 
two distinct populations: luminal epithelium and glandular epithelium (Figure 1c). 
The luminal epithelium is found on the main central lumen in the uterus and the 
glandular epithelium extends from the main lumen (Figure 1c). At birth, mice 
have formed a bipartite uterus, but lack the endometrial glands necessary for 
reproduction.  
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After puberty, a mammal will start ovulation through menstruation or estrous.  
The menstrual cycle length is determined by the first day of menses to the day 
before the menses of the next cycle begins. In humans the cycle is between 25-
30 days in length(13). During this time a group of ovarian follicles will mature with 
one eventually dominating the other follicles until the oocyte is released in 
ovulation(13). Meanwhile, the endometrium is primed by estrogen to proliferate 
and form a proper environment for an embryo(13). Once the egg is released, the 
follicular cells that have not been released secrete progesterone to prepare the 
uterus for implantation of the zygote(13).  If implantation does not occur, then the 
follicular cells degrade and menstruation begins when progesterone and 
estrogen levels are at their lowest point(13). The estrous cycle is divided into four 
stages: diestrus, proestrus, estrus, and metestrus(14). During diestrus, small 
follicles are present that begin to grow in proestrus(14). At the same time, the 
uterus begins to vascularize, endometrial glands grow, and the epithelium 
increases so that by estrus, there is a maximum amount of growth in the uterus. 
Estrus is when ovulation begins, where 10-20 eggs are released in mice from the 
ovarian follicles. Metestrus is similar to the beginning of menses. However, the 
tissue is not shed but rather reabsorbed into the uterus(14).  
This cycling is utilized to prime the female uterus for reproduction. Once an 
oocyte is fertilized the endometrial glands play a critical role in readying the 
uterine environment for the embryo. During the fertilization process the 
endometrial glands secrete proteins which (1) makes the uterus receptive to the 
blastocyst when it implants, (2) differentiates the endometrial stroma into decidua 
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and (3) nurtures the embryo during the generation of a placenta(15–18). The 
endometrial gland is a necessary part of female fertility that begins developing 
postnatally. 
 
1.2 Endometrial Gland Development 
Endometrial glands begin to bud in mice (Mus musculus) between 
postnatal day 5 (P5) and P7 from the luminal epithelium. Gland development 
does not happen as a synchronous event and each gland may be at a different 
stage of development. Around P7 endometrial glands begin to form teardrop-like 
structures(19) which then elongate into tubes around P11 that begin to branch by 
P21(19). After puberty, the glands look similar to a multi-branched tree, with the 
top of the tree connected to the central lumen (Figure 1d)(20). The endometrial 
gland epithelium can be distinguished from the luminal epithelium by expression 
of Foxa2 and increased Sox9 nuclear expression(21, 22). 
Gland development is a complex and dynamic process that takes the 
coordination of the luminal epithelium, the differentiating glandular epithelium, the 
endometrial stroma and the two layers of myometrium in order to form properly. 
Over the past two decades, scientists have been working to understand the 
complex molecular mechanism of this glandular development. There are a large 
number of genes that are involved in endometrial gland development (Table 1, 
Function: Gland Development). Utilizing a uterine specific Cre driven by the 
progesterone receptor (PR-Cre), it was found that Ctnnb1lox/lox; PR-Cre, 
Wnt7alox/lox; PR-Cre, and Wnt5alox/lox; PR-Cre mice do not form endometrial 
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glands. Wnt4-/- mice have a decrease in the number of glands compared to wild-
type endometrium when examined in kidney capsule grafting experiments(23). In 
addition, exposing postnatal mice from P3-P11 to high levels of progesterone 
causes a loss of gland formation that corresponds to a decrease in canonical 
Wnt signaling(24). Similar to Wnt signaling mutants, Sox17lox/lox; PR- Cre mice 
have an aglandular phenotype but curiously Sox17 is known as a negative 
regulator of Wnt signaling(25). Mice with increased Notch signaling in the uterus, 
Rosa26N1ICD/N1ICD; PR-Cre, do not form endometrial glands. This implicates 
numerous membrane receptor signaling pathways in endometrial adenogenesis, 
especially Wnt signaling(26).  
 
1.3 Wnt signaling 
Wnt signaling is associated with three different pathways, canonical, non-
canonical planar cell polarity, and the non-canonical calcium pathway (Figure 
2a). In planar cell polarity (PCP), Wnt ligands bind with Frizzled receptors leading 
to the recruitment of PCP protein DVL (dishevelled) which activates RAC (Ras-
related C3 botulinum toxin substrate), Cdc42 (cell division control protein 42), 
and RhoA (Ras homolog gene family member A) to affect actin organization 
(Figure 2a). The calcium/Wnt signaling begins with Wnt ligands binding to 
Frizzled receptors and ROR (retinoid-related orphan receptors) activating an 
assortment of kinases like JNK (Jun Kinase) and Protein Kinase C (PKC) (Figure 
2a). The most widely studied pathway however is the canonical Wnt signaling 
pathway. In canonical Wnt signaling, the Frizzled receptors bind with the LRP5/6  
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Gene Name Function 
Genetic 
Manipulation 
Female Reproductive-tract 
phenotype  References 
Aromatase Development Null Underdeveloped uteri  (27) 
Hoxa11 Development Null Excessive narrowing of the uterus (10) 
Vangl2 Development 
Spontaneous 
mutation; 
Grafting 
Experiments 
Septate vagina; Heterozygous mice 
have reduced gland formation; 
Mislocalization of E-cadherin; 
Disruption of planar cell polarity; 
Loss of actin polarization; Infertile (28) 
Follistatin 
Development; 
Differentiation 
Conditional 
Knockout 
Subfertile; poor decidualization; 
Abnormal endometrial luminal 
epithelium receptivity (29) 
Hoxa10/Hoxa11 
Development; 
Differentiation 
Transheterozy
gotes 
Partial transformation of uterus to 
oviduct; Excessive narrowing of the 
uterus (10) 
Activin-like 
Kinase 2 
(ALK2) Differentiation 
Conditional 
Knockout Subfertile; poor decidualization (30) 
Estrogen 
receptor a Differentiation Null 
Sterile; hypoplastic; does not go 
through estrous cycle (31)  
Estrogen 
receptor a/b Differentiation Null 
Extreme hypoplastic uterus; 
abnormal uterine architecture; 
sterile (31) 
Hoxa10 Differentiation Null 
Partial transformation of uterus to 
oviduct  (10) 
Hoxa13 Differentiation 
Hypodactyly 
mutation 
Cervical tissue transformed into 
uterus; hypoplasia of the vagina (32) 
IGF-1 Differentiation Null 
Underdeveloped uteri especially in 
myometrium (33) 
Ovo1  Differentiation Null 
Dilated uterus; Loss of luminal 
epithelium (34) 
Wnt7a 
Differentiation
; Gland 
Development 
Null; 
Conditional 
Knockout 
Uterine tissue transformed into 
vagina and oviduct transformed 
into uterus; Loss of uterine glands, 
Abnormal mesenchyme 
differentiation (35) 
PTEN 
Differentiation
; homeostasis 
Conditional 
Knockout 
At 1 month had endometrial 
cancer; 3 months endometrial 
cancer with myometrial invasion (36)  
Dicer 
Gland 
Development 
Stroma 
Conditional 
Knockout 
Reduced gland formation with few 
aberrantly in myometrium; 
decreased endometrial size; 
dysfunction of the uterotubal 
junction; reduced oviducts and 
uterine horns (37) 
Dlx5/6 
Gland 
Development 
Conditional 
Knockout 
Reduced gland formation; large 
lumen with deep invaginations  (38) 
Foxa2 
Gland 
Development 
Conditional 
Knockout Reduced gland formation; subfertile (21) 
Lef1 
Gland 
Development Null Loss of uterine glands (39) 
Notch1 
Gland 
Development Overactivation 
Loss of uterine glands; infertile; 
misregulation of hormone signaling (26) 
PR-Set7 
Gland 
Development 
Conditional 
Knockout 
Loss of uterine glands; infertile; 
increased endometrial epithelial 
cell death (40) 
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Progesterone 
Gland 
Development 
Increased 
amount at 
early postnatal 
days 
Loss of uterine glands; Infertile; 
impaired decidualization; no 
implantation and decreased 
implantation factors (41)  
Sox17 
Gland 
Development 
Conditional 
Knockout-
stroma Loss of uterine glands; infertile (25) 
Sox9 
Gland 
Development Overactivation 
Increase in uterine gland formation; 
uterine cysts  (22) 
Timp1 
Gland 
Development Null 
Late onset Increase in uterine 
gland formation; Abnormal 
endometrial luminal epithelium and 
shape (42) 
Wnt11 
Gland 
Development 
Conditional 
Knockout Early increases in gland numbers (43)  
Wnt5a 
Gland 
Development, 
Differentiation Null 
Short & coiled uterine horns, lack of 
cervical/vaginal structures; loss of 
uterine glands (4) 
Wnt4 
Gland 
Development, 
Homeostasis 
Conditional 
Knockout 
Reduced gland formation, 
abnormal luminal epithelium (23) 
Lgr4 
Gland 
Development, 
Pregnancy 
Conditional 
Knockout 
Reduced gland formation; 
decreased LIF secretion; subfertile; 
impaired decidualization (44)  
Cdh1  
Gland 
Development; 
Homeostasis 
Conditional 
Knockout 
Loss of uterine glands; Loss of 
epithelial markers; Loss of 
endometrial stroma markers; 
Increased apoptosis and 
proliferation; Decreased Wnt and 
Hox expression (45) 
Ctnnb1 
Gland 
Development; 
Homeostasis 
Conditional 
Knockout 
Loss of uterine glands, later k14 
positive stratified squamous 
epithelium; unable to go through 
decidualization reaction (46) 
Smo 
Gland 
Development; 
Homeostasis; 
Stromal 
Development Overactivation 
Infertile; No decidualization; Uterine 
hypertrophy; reduced gland 
formation; stratified squamous 
luminal epithelium; Uterine stroma 
change extracellular matrix (47) 
Ctnnb1 Homeostasis Overactivation Hyperplasia of the gland (46)  
Estrogen 
receptor b Pregnancy Null Subfertile (smaller litters) (48) 
Kiss1  Pregnancy Null Decreased Lif1 secretion levels (49) 
Lif Pregnancy Null 
Inability of blastocyst to implant; No 
decidualization (15, 16)  
Notch1 Pregnancy 
Conditional 
Knockout Reduced decidualization (50) 
Table 1 Genes involved with Uterus Development and Homeostasis 
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(low density lipoprotein receptor related protein 5/6) co-receptors causing DVL to 
be phosphorylated which recruits a scaffolding protein, Axin. Axin in complex with 
APC (adenomatous polyposis coli), CK1a (Casein kinase 1a) and GSK-3b 
(glycogen synthase kinase 3b) create the destruction complex. This complex 
targets b-catenin for multiple phosphorylation events leading to recruitment of the 
ubiquitin ligase complex which ubiquitinates b-catenin and leads to proteasomal 
degradation. Thus, when Axin is recruited away from this complex, b-catenin is 
able to translocate into the nucleus and bind with the LEF/TCF (Lymphoid 
enhancer factor/T-cell factor) family of proteins derepressing downstream Wnt 
target genes (Table 2). Interestingly, while b-catenin is a key component of 
canonical Wnt signaling, the majority of b-catenin is found at adherens junctions. 
There is a debate on whether junctional b-catenin and cytoplasmic b-catenin 
pools mix. Another adherens junction protein was also recently found to play a 
role in Wnt signaling, a-catenin. a-catenin increases APC binding to b-catenin 
allowing for increased degradation of b-catenin and in theory a decrease in 
canonical Wnt signaling(51). Wnt signaling is thought to be a major pathway in 
endometrial development. As was previously discussed Wnt ligands and b-
catenin were found to affect both Mullerian duct formation and endometrial 
adenogenesis. Since the loss of b-catenin disrupts endometrial adenogenesis, 
we can postulate that canonical Wnt signaling is necessary during endometrial 
gland development. Many of the Wnt ligands, mentioned in section 1.1 Female 
Reproductive Tract Development, that are associated with endometrial gland   
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Figure 2 Wnt, Notch, and Hippo signaling pathways.  
There are three main types of Wnt signaling (i) canonical signaling, (ii) non-canonical 
calcium signaling, (iii) planar cell polarity (a). (i) When Frizzled receptors are activated by 
LRP in canonical Wnt signaling it inhibits the destruction complex 
(Axin/APC/GSK3b) from phosphorylating b-catenin. b-catenin is then able to translocate 
to the nucleus where it increases canonical Wnt target genes. (ii) Frizzled receptors and 
retinoid-related orphan receptors (RORs) bind to the Wnt ligand activating 
Phospholipase C (PLC) which in turn activates many different proteins including Inositol 
trisphosphate (IP3) that utilizes calcium Ca2+ to activate calmodulin. Activation of 
Calmodulin causes Transforming growth factor beta-activated kinase 1 (TAK1) to 
activate Nemo Like Kinase (NLK) which inhibits target genes. (iii) In Planar cell polarity, 
when Frizzled is activated by the Wnt ligand it binds to intracellular protein, Disheveled 
(Dvl) which recruits and activates Daam1. Daam1 then activates RhoA which through 
Rho-associated kinases (ROCK) manipulates and rearranges the cytoskeleton (a). 
Notch signaling has a membrane-bound ligand and receptor that must interact for proper 
cleavage of the receptor (b). The Notch receptor is enzymatically cut in the Golgi 
apparatus (S1 Cleavage), this is necessary for the Notch receptor to be activated. Once 
the Notch ligand binds to the Notch receptor, the ADAM (a disintegrin and 
metalloprotease domain) proteins cleave the extracellular matrix of the Notch receptor 
(S2 cleavage). This allows for the g-secretase complex to cleave the transmembrane 
domain (S3 cleavage) generating the Notch Intracellular Domain (NICD). The NICD is 
translocated to the nucleus where it interacts with TCF/Lef family members to increase 
transcription of Notch downstream targets (b). Wnt signaling has been shown to be 
manipulated by the tumor suppressor Merlin in different contexts (c). One example is 
Merlin has been found to inhibit canonical Wnt signaling within Schwannoma cell lines. 
Kim et al. showed that unphosphorylated Merlin inhibits the ability of Frizzled and LRP6 
to interact while phosphorylated Merlin no longer binds LRP6 allowing it to interact with 
Frizzled (i)(52). Merlin blocks FOXM1 (forkhead box protein M1) from Wnt signaling in 
pancreatic cancer cell lines(53). Loss of Merlin stabilizes FOXM1 protein and increases 
the amount of FOXM1 that can increase canonical Wnt signaling (ii)(53).The Hippo 
signaling pathway is active when YAP/TAZ (Yes associated protein/Transcriptional 
coactivator with a PDZ-binding domain) are not active (translocated to the nucleus and 
increasing target transcription) (d). Merlin activates the MST1/2 (mammalian ste20 
homologs 1/2), Sav (Salvador), MOBKL A/B (Mps one binder kinase activator-like A/B), 
and Lats1/2 (Large tumor suppressor 1/2) group of proteins which inhibit YAP/TAZ 
nuclear translocation by phosphorylation (d)(54). Targets of YAP/TAZ include BIRC3 
and CTGF (d). 
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development are utilized more in planar cell polarity (PCP), however whether 
ligands are canonical or non-canonical is tissue specific. The Lpt mouse, is a 
PCP mutant mouse model that does form endometrial glands, suggesting that 
PCP is not necessary for proper endometrial adenogenesis(28).  
Apicobasal polarity has also been shown to be important in Wnt signaling. 
In Drosophila, Wnt forms a gradient with a majority of the dWnt localizing to the 
apical membrane. Interestingly, if dWnt is mutated, basally localized dWnt does 
not rescue the phenotype(55). Also, proper localization of the Frizzled receptor to 
the apical or basal membrane was shown to determine whether the receptor 
activated canonical Wnt signaling or planar cell polarity(56). Understanding the 
role apicobasal polarity plays in Wnt signaling may contribute to understanding 
the role of Wnt in endometrial development and homeostasis.  
Curiously, a constitutively active b-catenin mouse model (Ctnnb1f(ex3)/+; 
PR- Cre), exhibits endometrial gland hyperplasia(46). The endometrial gland is 
hypothesized to be where endometrial cancer originates. Thus, the phenotype in 
Ctnnb1f(ex3)/+; PR- Cre mouse models may represent an early form of endometrial 
cancer. In fact, a recent study showed that b-catenin mutations in low-grade and 
early stage endometrial cancer patients correlated with an increased risk for 
recurrence and metastasis. This is fascinating because this is a population of 
patients that have a low risk of recurrence(57).  This implies that Wnt signaling is 
critical within the uterus and an important factor to consider in endometrial 
cancer.  
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Gene Name 
Canonical 
Pathway Located in Endometrium? Reference 
HEYL Notch 
Medium mRNA and low protein diffuse 
in tissue (58)  
HES1 Notch Low mRNA levels (59)  
HEY1 Notch Low mRNA levels (58) 
HEY2 Notch 
Low mRNA and medium protein in 
tissue (58) 
p21 Notch 
Medium RNA and medium protein in 
glands (60) 
Axin2 Wnt Medium protein levels in glands (61) 
c-Myc Wnt 
Medium protein levels in glands; 
mutant mice have decreased fertility (62) 
Sox9 Wnt High protein levels in glands (63)  
Ccnd1 Wnt Low protein levels in glands (64) 
Table 2 Downstream Targets of Notch and Wnt Signaling 
*This is not a comprehensive list just those examined within this study.  
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1.4 Endometrial Cancer 
Endometrial cancer is the fourth most common female cancer within the 
United States and the fifth most common in the world(65, 66). The highest 
incidences of endometrial cancer are observed in the United States, Canada, 
and Europe. There are an estimated 10,920 American deaths attributed to 
endometrial cancer, making it the sixth most deadly female cancer in the US(66). 
Unlike most other cancer types, the rate of endometrial cancer incidence is 
increasing and is projected to rise to the third most common female cancer in the 
United States within the next 25 years(67). In fact, there has been a 2.3% rise in 
the rate of endometrial cancer from 2008-2012 with a portion of that increase 
coming from premenopausal women and a 2% increase in the number of deaths 
related to the disease. There are some disparities within races with endometrial 
cancer, for instance while there was an 84% survival rate in Caucasian women 
between 2006-2012, black women saw more than a 20% decrease in survival 
within the United States. These differences may be caused by disparities in 
socioeconomic situations. Approximately 95-98% of all endometrial cancers arise 
in epithelial cells of the endometrium. Traditional classification of endometrial 
carcinomas is based on clinical and endocrine features as well as 
histopathological characteristics. Within the last two decades, molecular 
classification has served as an important advancement to further organize these 
tumors(68–70). 
Pathologically, there are several different histotypes of endometrial 
cancer, such as clear cell, serous and endometrioid, the most common histotype 
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(~80%). Standard of care for endometrial cancer generally consists of removing 
the ovaries (bilateral salppingo-oophorectomy) and a hysterectomy. Depending 
on the stage of the disease, lymph nodes may also be removed. Women still in 
their reproductive years may retain their ovaries, preventing early menopause. 
Surgery is normally followed by adjuvant chemotherapy in cases determined to 
have high risk of recurrence by the histology (serous) and in cases where cancer 
is discovered in resected lymph nodes or non-uterine sites. 
Clinically, the aggressiveness of the disease is determined during surgical 
staging and by histological grade. Staging and tumor grade have a fundamental 
importance in treatment decisions. The Federation of Gynecology and Obstetrics 
(FIGO) staging used by gynecological oncologists world-wide, place endometrial 
cancers in one of four stages. Stage I is when the tumor has not spread outside 
of the uterus and is separated into two subcategories: tumors that have invaded 
50% or less into the myometrium (Stage IA) and tumors that have invaded more 
than 50% of the myometrium (Stage IB). Stage II is defined as when the tumor 
has spread into the cervix. Stage III is when the tumor has spread from the 
endometrium, cervix, and into other parts of the female reproductive tract (FRT) 
and/or lymph nodes. Finally, Stage IV is separated into two subcategories: when 
the tumor has invaded into the bladder area (Stage IVA) or cells have 
metastasized into distant organs or lymph nodes (Stage IVB). Tumor grade 
identifies at what level tumor cells resemble normal endometrial epithelium. 
Grade 1 is when the endometrial tumor cells are well-differentiated and are 
predominantly comprised of glandular growth with 5% or less of abnormal tissue. 
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Grade 2 tumors are moderately-differentiated with between 6-50% of the tissue 
considered cancerous. Grade 3 tumors are considered poorly-differentiated 
tumors, with a majority of the tissue maintaining very little to no recognizable 
epithelial growth patterns. Patients having grade 3 endometrioid tumors have a 
poor prognosis, similar to non-endometrioid tumors (serous and clear cell). 
Endometrial cancers are also classified more broadly to simplify the disease into 
two categories, Type I and Type II, based on histology, molecular characteristics, 
and clinical diagnosis of the tumors. It should be noted that this simplified 
classification is not utilized in the clinic to determine treatment plans. Type I 
tumors include grade 1 and grade 2 endometrioid tumors. These tumors are less 
likely to metastasize and have a relatively good prognosis. These tumors are 
also highly correlated with obesity and excess estrogen. Type I tumors usually 
have mutations within the AKT/PI3K pathway. Grade 3 tumors are considered 
Type II along with other non-endometrioid cancers. These tumors are seen at an 
older age and are more aggressive with a poor prognosis. Type II tumors 
frequently have p53 mutations estimated in some studies to be present in 90% of 
cases. Type II tumors also have mutations in other genes including E-cadherin 
(80-90%), p16 (40%), or Her2 (45-80%) and not always independent of one 
another(71). It is commonly thought within the field that Type I and Type II tumors 
form independently and do not progress from one type to another. While a 
majority of Type I and Type II tumors are separated by specific pathway 
mutations, there is some overlap.  
 19 
My work focuses on Type I endometrioid tumors where the epithelium is 
still identifiable with key epithelial markers. Type I endometrial cancers commonly 
have PTEN (Phosphatase and Tensin homolog) inactivation (50-80%), 
microsatellite instability (20-45%), K-ras mutations (10-30%), or b-catenin 
mutations (20%) though not always separately(57, 71). Since endometrial 
hyperplasia has PTEN inactivation in about 50% of cases, it is hypothesized that 
Type I tumors may be progression of hyperplasia. There is a small subset of 
Type I tumors that have p53 mutations, Her2 overexpression, p16 inactivation, or 
E-cadherin alterations(71).  
Recently, Notch signaling has also been found to be downregulated in 
early stage and low-grade endometrial cancer cases(72, 73). Multiple Notch 
receptor activation mouse models have shown that Notch is necessary for proper 
FRT development(26, 74). Notch signaling is involved in both endometrial 
development and tumorigenesis, however no one has examined how Notch may 
be important in uterine homeostasis.  
 
1.5 Notch signaling 
Notch signaling consists of a single pass transmembrane receptor that 
binds to an adjacent single pass transmembrane ligand. This interaction opens 
up the S2 cleavage site that ADAM (A Desintegrin And Metallopeptidease) family 
secretases severs (Figure 2b). This is followed by cleavage at two 
intramembrane sites (S3) by g-secretase, an enzymatic protein complex, 
generating the Notch Intracellular Domain (NICD). It is not clear how NICD 
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localizes to the nucleus from the cell membrane but once present at the nucleus, 
the NICD is imported into the nucleus via importin a/b1 signaling(75). NICD 
interacts with CSL (CBF1, Suppressor of Hairless, Lag-1) to increase 
downstream target gene expression (Table 2, Figure 2b)(76). Mammals have 
four Notch receptors (Notch1-4) and five canonical Notch ligands (Jag1-2, Delta-
like [Dll]1, 3, 4). While there are differences between the intracellular domains of 
Notch1-4, data has shown that the intracellular domains are interchangeable(77). 
Previous work has demonstrated that overall levels of active NICD determine 
how Notch signaling is functioning within the cell(77, 78). Notch signaling has a 
wide variety of downstream targets and cellular functions depending on 
spatiotemporal context.  
Notch signaling is necessary for proper fate determination in the glandular 
and luminal epithelium of the stomach in chicken(79). Specifically, overactivation 
of Notch signaling promoted glandular epithelium, while inhibition of Notch led to 
luminal epithelium within the stomach in chicken(79). A uterine conditional 
overactivation of Notch (Rosa26N1ICD/N1ICD; PR-Cre) in mice caused a loss of 
endometrial glands as previously discussed(26). Interestingly, while histologically 
there are no endometrial glands, glandular specific markers were found to 
express throughout the luminal epithelium(26). Given that in the chicken 
stomach, overactivation of Notch signaling causes glandular epithelium 
differentiation, potentially these mice have no luminal epithelium present and the 
entire endometrium is glandular epithelium(26, 79).  
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Apicobasal polarity is important for proper Notch signaling.  The 
apicobasal polarity regulator, Merlin, is necessary for correct localization of the 
Notch receptor in Drosophila(80). In addition, Par3, an apicobasal polarity 
protein, causes asymmetric localization of  Notch signaling in radial glial cells 
during asymmetric division(81). In fact, asymmetric divisions, usually governed 
by polarity proteins, promotes Notch signaling during epidermal development in 
the mouse as well(82). Understanding apicobasal polarity and the role it plays in 
cell signaling may help determine how it is involved in endometrial development 
and homeostasis.  
 
1.6 Apicobasal Polarity 
Each cell in an organism has an intricate spatial patterning of proteins and 
organelles within the membrane and cytoplasm. This patterning is necessary for 
proper functioning of the cells. The composition of cells and tissues are also 
specifically organized at either a tissue or organ level, respectively. For example, 
the uterus is organized (from outermost to inner layers) with the smooth muscle 
layers surrounding the endometrial stroma with vasculature and glands 
intertwined. The stroma encases the highly polarized, simple epithelium that 
surrounds the lumen of the uterus.  
At a cellular level, apicobasal polarity determines the side of the cell that 
faces the extracellular matrix and the membrane that faces into the lumen of the 
tissue. Polarity is initially established through external cues in the extracellular 
matrix and cell:cell contacts. There are three major complexes necessary for  
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Figure 3 Apicobasal Polarity and Cell adhesion.  
Within a single epithelial cell, there is a gradient of apicobasal polarity proteins with a 
majority of basal polarity proteins localized on the basal membrane (a). The basal 
complex is the Scrib/Lgl/Dlg. The majority of apical proteins are localized on the apical 
membrane including two apical complexes. The two apical complexes include the 
Crb3/Pals1/Patj complex and Par3/aPKC/Par6 complex (a). The Par complex switches 
between Par3 and Cdc42 (b). When aPKC/Par6 is in complex within Par3 it causes 
proper apical localization but aPKC is inactive(83). When Cdc42 is in complex with 
aPKC/Par6, aPKC is active but the complex is more diffuse within the cell(83) (b). The 
apical junctions in epithelial cells include the tight junction and the adherens junction (c). 
The tight junction consists of transmembrane proteins: occludin, claudin, and JAMs 
(junction adhesion molecules). In addition, there are the scaffolding proteins Zonula 
Occludens (ZO) 1-3. The adherens junction consists of cadherin (E-cadherin) molecules 
that bind extracellularly to other cadherin proteins. The cadherins bind to b-catenin and 
a-catenin (c). Proper establishment of apicobasal polarity is intertwined with apical 
junction formation (d). When two cells come into contact, primordial adherens junctions 
form. Par3 is recruited to the primordial junction, followed by the aPKC/Par6 complex. 
Once Par3/Par6/aPKC are recruited to the primordial junction, junctional maturation 
occurs forming adherens junctions and tight junctions (d). 
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apicobasal polarity establishment: the Par complex, the Crumbs complex, and 
the Scribble complex (Figure 3a). These complexes have been found to work in 
conjunction with each other to form a protein based gradient in the cell. Specific 
apical and basal kinases oppose each other within the complexes to place apical 
proteins on the apical perimeter and basal proteins on the basal side(84–87).  
The Crumbs complex is localized to the apical tight junctions and was 
initially discovered to cause a dispersed epithelial cuticle when disrupted in 
Drosophila melanogaster(88). Mammals have three major isoforms of Crumbs 
(CRB1-CRB3)(89–91). The CRB3 isoform is in a complex with PALS1 (Protein 
associated with Lin-17) and PATJ (PALS-1 associated tight junction protein) 
creating the Crumbs polarity complex(90). Crb3 is expressed in many of the 
tissues in the human body including in the endometrial glandular epithelium(92, 
93). Interestingly, the Crb3-/- mouse does not show apicobasal disruption in any 
of the examined epithelial tissues(94). This is vastly different than what is 
observed in three-dimensional (3D) cell culture where cells with Crb3 knockdown 
are unable to form proper lumens(95, 96). The Crb3-/- mice do show a decrease 
in Patj and Pals1 showing that Crb3 is involved in Pals1/Patj expression(94). Patj 
knockdown and Crb3 overexpression in epithelial cells also causes defects in 
tight junction formation, however, Patj has not been mutated in mice(97–101). 
Pals1-/- mice do have a loss of adherens junctions in select epithelium including 
neural tube epithelium(102). The role the Crumbs complex plays in cell polarity is 
specific to the cell type and relates to the other polarity complexes. 
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The Scribble complex localizes to the basal surface, the membrane 
touching the extracellular matrix, and is necessary to define the basolateral 
membrane(103). The complex contains Scribble, Discs Large (Dlg) and Lethal 
Giant Larvae (Lgl) proteins(103, 104). There are four major homologues of Dlg in 
mammals (Dlg1-4) and two homologues of Lgl in mammals (Llgl1-2). Tissue 
specific knockout of Scribble in the mammary gland disrupts apicobasal polarity 
resulting in loss of tissue architecture(105). However, homozygous Scribble 
mutants, like the spontaneous circletail (ScribCrc/Crc) mutant, have severe neural 
tube closure defects and stereociliary bundle disorganization in the cochlea 
similar to Planar Cell Polarity (PCP) mouse mutants(106, 107). Drosophila dlg 
mutants have loss of apicobasal polarity of epithelial cells(108). Interestingly, 
Dlgh3 mutant (Dlg3tP038A02/Y) mice exhibit low penetrance of embryonic lethality 
and mislocalization of aPKC and apical junction markers at E8.5(109). Dlgh2-4 
knockout mice are viable and have behavioral defects, similar to humans with 
DLG2-4 mutations that have schizophrenia or mental retardation(110–114). 
Dlgh1-/- mice have perinatal lethality and urogenital defects as well(115, 116). 
Apicobasal polarity has not been examined in depth in the Dlgh1, 2, or 4 null 
mice. Llgl1-/- mice die at birth from hydrocephalus and Llgl2-/- mice have placental 
development defects(117, 118). Llgl1-/- and Llgl2-/- mice do not exhibit disruption 
in apicobasal polarity in the organs examined(117, 118). However, in vitro 
studies showed that when Llgl1-2 were knocked down in combination, apicobasal 
polarity is disrupted(87).  In Drosophila, Lgl regulates Notch intracellular domain 
(NICD) through endosomal trafficking where there is an increase in vesicles and 
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an upregulation of Notch target genes(119). This is mirrored in Llgl1 depletion in 
Zebrafish (Danio rerio) where Notch signaling increases(120). The Scribble 
complex is involved in many functions including planar cell polarity, actin 
cytoskeleton regulation, and vesicular trafficking(105, 106, 119), but is most 
known for the role it plays in apicobasal polarity. 
The Scribble complex is involved in apicobasal polarity through an 
antagonistic relationship with the Par complex(87). The Par complex is 
composed of Par3 (Partitioning defective 3 homolog), aPKC (atypical protein 
kinase c), Cdc42 (cell division protein 42 homolog), and Par6 (Partitioning 
defective 6 homolog). aPKC phosphorylates Lgl, which prevents apical 
localization of Lgl and the entire Scribble complex in the Drosophila 
ectoderm(121). In mammalian cell lines, it was shown that Lgl competitively 
binds to aPKC in place of Par3 or Cdc42 allowing the phosphorylation of 
aPKC(85). When aPKC is at the basolateral membrane this leads to an 
overabundance of Lgl binding and an inactivation of the Par complex since 
neither Par3 or Cdc42 can bind. aPKC is a Serine/Threonine protein kinase that 
is necessary to maintain the antagonistic relationship with the Scribble complex. 
The proteins that compose the Par complex are involved in multiple 
functions, not just apicobasal polarity.  Par3 is a scaffolding protein that has three 
PDZ domains that bind proteins including PTEN, cell junction proteins, and Par6. 
In addition, Par3 directly interacts with aPKC. Interestingly, aPKC can 
phosphorylate Par3 causing dissociation of Par3 from the Par6/aPKC complex. 
Par3 binding to aPKC/Par6 is necessary for proper apical localization (Figure 
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3b)(83). Cdc42 is in complex with activated aPKC and is thought to be necessary 
for activation (Figure 3b)(83).  
In epithelial cells, cell polarity proteins act in tandem with specific cell:cell 
or cell:matrix complexes. The Par complex is established through cellular contact 
(Figure 3d). In cell culture when two cells make contact, the adherens junction 
protein, E-cadherin is recruited to the site of contact. This initiates the formation 
of primordial apical adherens junctions. Par3 is recruited to the primordial 
junction through the tumor suppressor protein Merlin and junctional adhesion 
molecules (JAMs)(122, 123). Par6/aPKC subsequently localize to the junction 
where Par3 binds to the complex (Figure 3d).  
Par3 was initially found in C. elegans in 1988 when Kemphues et al. 
showed it was necessary for asymmetric division of the one-cell C. elegans 
embryo(124). Par3 has three major isoforms(125). The 180kD and 150kD 
isoforms both have the aPKC binding domain, while the 100kD isoform does not 
bind to aPKC(125). Since the 100kD isoform does not bind to aPKC it is thought 
to not play a role in apicobasal polarity. My dissertation work focuses on the 
isoforms that bind aPKC and are involved in apicobasal polarity. Par3 has 
multiple functions within the cell including the regulation of primary ciliogenesis, 
PI3K/AKT signaling, and apicobasal polarity(124, 126–129).  The ability of Par3 
to bind to Kif3a, a microtubule motor protein for cilia, is necessary for proper 
primary cilia formation in cell culture(126). Par3 also binds PTEN and is required 
for proper localization of PTEN in Drosophila and cell culture(130, 131). It was 
determined that PTEN also played a role in proper Par3 localization and tight 
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junction function, thus both are necessary for proper apical membrane 
establishment(127, 131, 132).  
Par3 is necessary for the proper establishment of the apical cell 
membrane in model organisms and mammalian cell culture(128, 129). Par3 was 
found to be critical for correct asymmetric division of radial glial cells into a 
daughter radial glial cell and a neuron. This was found to be mediated through 
asymmetric division of Notch signaling(81). Studies of the Par3 knockout mouse 
(Par3DE3/DE3) showed a failure of epicardial development leading to embryonic 
lethality between embryonic day 12.5-14.5 (E12.5-E14.5)(133). The epicardial 
progenitors are unable to form cysts that are necessary for proper formation of 
the epicardium(133). This inability to bud into cysts is hypothesized to be from 
mislocalization of polarity proteins(133). Defective epithelial cyst formation has 
also been observed in Par3 knockdown cells(72, 134).  Besides aberrant heart 
development, the Par3DE3/DE3 mice also exhibit some amount of stunted growth at 
E9.5 and a shortened tail(133). It is suggested the reason there are not more 
evident issues with other epithelial organs at earlier embryonic stages is because 
other proteins like Par3L or Par3b compensate for the loss of Par3. Conditional 
Par3 knockout (Par3lox/lox; K14-Cre hereafter referred to as Par3eKO) within the 
skin causes an inside-out barrier defect in newborn pups with mislocalization of 
tight junction proteins, ZO-1 and claudin-1(135). An inside-out barrier defect is 
when the barrier that holds moisture and other substances in the body is 
defective, thus a severe barrier defect would cause lethal dehydration. A similar 
phenotype is observed in Claudin-1 null mice(136). Except for the mislocalization 
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of Claudin-1, the tight junction loss reverts back to wild-type by P58 in Par3eKO 
mice(135). This may be attributable to a compensatory mechanism. As the 
Par3eKO mice age there is an increase in hypertrophic and multilobular 
sebaceous glands(135). In addition, there is an increase in overall epidermal 
thickness in Par3eKO mice at birth(135). Further phenotypes related to cancer 
have been identified in Par3 knockout mice that will be discussed in 1.7 
Apicobasal Polarity in Cancer(137, 138). Par3 has also been found to be critical 
in mammary gland development(139). Par3 knockdown caused a 44% decrease 
in growth of mammary glands across the fat pad when transplanted compared to 
wild-type control cells(139). In addition, the Par3 knockdown glands were 
unorganized, multilayered, and small(139). It was found that the aPKC binding 
domain of Par3 was necessary to rescue the growth of the mammary gland(139).   
Atypical Protein Kinase C (aPKC) is one of three subfamilies of PKCs 
(novel PKC and classical PKC) that contains two proteins PKCz and PKCl/i. 
aPKC proteins have various roles through tissue development that have been 
observed in mouse models. Pkcz null mice are viable but show abnormalities in 
the ratio of B:T cells caused by NF-Kb signaling(140). The important role of 
aPKC proteins in the immune system was confirmed when both Pkcl/i and Pkcz 
affect the ability of T lymphocytes to properly go through asymmetric 
division(141). This disruption of asymmetric division is also observed with other 
polarity mutants in different cell types(81). Pkcl/i has been implicated in the 
development and maintenance of many organs including the kidney and the hair 
follicle(142–147).  When Pkcl/i is deleted in the developing kidney nephrons 
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(aPkcllox/lox; Nphs1-Cre) it causes renal dysfunction by 4 weeks of age leading to 
death by about 6 weeks of age. The renal dysfunction is due to mislocalization of 
nephrin and podicin proteins which are necessary for proper formation of the 
podocyte tight junction(145), similar to polarity proteins in other epithelium. Loss 
of Pkcl in the epidermis (aPkcllox/lox; K5-Cre) causes progressive hair loss due to 
a slow regression of the bulge stem cell niche through an increase in asymmetric 
cell divisions and a decrease in symmetric cell divisions(147).  
While Par6 has not been thoroughly studied in vivo, there is a 
Par6a mutant (PARD6atm1.1(KOMP)Vlcg/tm1.1(KOMP)Vlcg) generated by the International 
Knockout Mouse Consortium with a few noted phenotypes including changes in 
T-cell numbers, aberrant bone mineral content and changes in body fat(148). 
There has been some work that links Par6 to cancer. Par6 was found to promote 
proliferation of breast cancer cells and epithelial-mesenchymal transition (EMT) 
through TGFb in non-small-cell lung cancer (NSCLC) cell lines(149, 150). High 
levels of Par6 have also been correlated with aggressive prostate cancers and 
EMT in breast cancer indicating the Par complex may be involved and promote 
tumorigenesis.  
 
1.7 Apicobasal Polarity in Cancer 
 Apicobasal polarity is a characteristic of all epithelial tissues. A majority of 
solid tumors lose apicobasal polarity, however in the past it was thought to be a 
secondary effect of the driver mutations and cancer hallmarks, such as EMT that 
are necessary for cancer metastasis(151). Recently, evidence has been 
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mounting that implicates a major role of polarity in the progression of cancers 
(Table 3). The Crumbs3 protein from the Crumbs complex has been shown to 
suppress features of tumorigenesis (metastasis, pluripotency) in normal kidney 
and breast cell lines(152, 153). The Scribble complex proteins, Scribble and Dlg, 
are targeted by the Human Papillomavirus (HPV) for degradation and this 
decrease of protein at the membrane is correlated with higher grade and more 
invasive cervical malignancies(154–156). Scribble deficiency in mice predisposes 
them to prostate cancer(157). Interestingly, Scribble is mislocalized in prostate 
cancer and basal breast cancer patients and correlate with a poor prognosis(157, 
158). While there are some excellent reviews on both the involvement of the 
Crumbs and Scribble complexes in cancer(159, 160), my dissertation work 
focuses on the Par complex.  
The Par complex has been found to be lost in a variety of cancers 
including breast, colon, and gastric cancer(92, 93, 161). Par6 has been shown to 
be necessary for EMT in a breast cancer cell line when TGFb (transforming 
growth factor b) signaling is disrupted however no in vivo studies have confirmed 
this(149).  There is a decrease in Par6 protein levels in stomach and colon 
cancer however this has not been examined in detail(92, 93). Pkcz has been 
found to act as a tumor suppressor while Pkci acts as an oncogene in some 
mouse models. Pkcz-/- lungs that were stimulated by the oncogene, Ras, had a 
20% increase in tumor burden compared to wild-type Ras-stimulated 
lungs(162). Galvez et al. determined that Pkcz  suppresses Interleukin-6 
(IL6)(162), an inflammatory signal that is increased in cancer patients(163).  
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Gene (Protein) Uterine Phenotype 
Experimental 
Cancer-related Data  Human Cancer Data References 
Crb3 (Crumbs3)  Not known 
Loss contributes to 
tumorigenesis; 
targeted by viral 
oncoproteins for 
degradation 
Amplification in sarcoma, 
neuroendocrine prostate, breast 
cancer, paraganglioma; deletion 
in uterine, stomach and lung 
adenocarcinoma 
 (152, 164–
166) 
Dlg1 (Dlg1) 
 Absent vagina, No 
lateral fusion of the 
Mullerian ducts 
Directly interacts with 
APC and PTEN; with 
Dlg3 and Dlg4 
interacts with 
oncoprotein Net1; 
DLG paralogs targeted 
by human virus 
oncoproteins;  
Dlg1 somatic mutations in breast 
cancer 
 (116, 166–
168) 
Dlg2 (Dlg2)  Not known  Not known 
Amplification in breast, prostate, 
ovarian, and lung cancer; 
mutations in melanoma, uterine, 
stomach, lung, stomach, 
colorectal, cholangiocarcinoma, 
bladder cancer (164, 165) 
Dlg3 (Dlg3)  Not known 
Associates with APC; 
cancer cell lines 
overexpression results 
in suppression of cell 
growth, cell migration, 
and invasion; interacts 
with oncoprotein Net1 
Dlg3 is downregulated in gastric, 
esophageal, and glioblastoma; 
upregulated in serous ovarian 
carcinoma and breast cancer  (169–171) 
Dlg4 (Dlg4)  Not known 
Interacts with 
oncoprotein Net1; 
degradation of Dlg4 by 
HPV 
Deletion in prostate, pancreas, 
bladder, liver, colon, and 
lymphoma 
(164, 165, 
171, 172) 
Dlg5 (Dlg5)  Not known 
Loss induces breast 
cancer cell migration 
and disruption of 
apicobasal polarity; 
Loss shows increases 
in Hippo signaling in 
breast cell lines 
Genetic variant (R30Q) 
associated with inflammatory 
bowel disease and Crohn's 
disease; Dlg5 loss in prostate 
cancer; Dlg5 upregulated in 
gastric and pancreatic cancers 
 (164, 165, 
173–175) 
Llgl1 (Lgl1)  Not known 
Lgl1 KO mice have 
brain dysplasia and 
invasion 
Loss of copy number correlates 
GBM poor survival; 
lost/downregulated in melanoma, 
prostate, breast, and colon 
cancers; Lgl1 loss correlates with 
 (117, 164, 
165, 
169)(117) 
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advanced staging of colorectal 
cancer and melanoma 
Llgl2 (Lgl2)  Not known 
Mutations in zebrafish 
causes epidermal 
hyperproliferation 
Decreased 
expression/mislocalization in 
gastric cancers; low levels 
correlated with colorectal cancer 
aggressiveness 
 (169, 176, 
177) 
Mpp5 (Pals1)  Not known 
Pals1 is necessary for 
cerebellar progenitor 
cell proliferation; 
Important for E-
cadherin membrane 
trafficking in MDCK 
cells 
Mutations in bladder, uterine, 
cholangiocarcinoma, colorectal, 
adenoid cystic carcinoma, 
melanoma; amplification of 
prostate esophagus, stomach, 
head & neck, ovarian, and 
sarcoma; deletions in adenoid 
cystic carcinoma  
(164, 165, 
178, 179) 
Pard3 (Par3) Not known  
Par3 KO in skin delays 
Ras-induced 
papillomas but 
predisposes skin to 
keratoacanthoma; 
Par3 KD increases 
metastasis in breast 
cancer 
Downregulated in breast cancer 
and improper localization in 
metastatic disease; proper 
localization decreased in 
metastatic disease; 
Downregulated in ESCC & 
correlated with metastasis; 
Deletion in HNSCC and 
glioblastoma; Upregulated and 
associated with poor prognosis in 
hepatocellular carcinoma  
(137, 180–
183) 
Pard6a/Pard6b/Pard6g 
(Par6) Not known 
Par6 promoted 
proliferation of breast 
cancer cells; 
Establishes front to 
rear polarity; 
necessary for cancer 
cell invasion and 
cell:cell adhesion; 
Par6 phosphorylation 
induces E-cadherin 
reduction and TGFb 
EMT in NSCLC cells 
Par6 thought to be pro-
tumorigenic in breast cancer; 
Par6b upregulated in breast 
cancer and associated with EMT 
characteristics; high Par6 in 
stromal cells correlates with 
better prognosis in NSCLC; high 
levels correlated with aggressive 
prostate cancers 
 (149, 150, 
164, 165) 
Patj (Patj)  Not known 
Targeted by viral 
oncoproteins for 
degradation 
Mutations in melanoma, lung 
adenocarcinoma, head & neck 
cancer, cholangiocarcinoma  (164–166)  
PRKCI (PKCi)  Not known 
Promotes breast 
cancer cell metastasis; 
promotes tumor 
growth for 
glioblastoma cells; 
promotes 
Cholangiocarcinoma 
cell migration, 
metastasis and 
proliferation 
Upregulated in NSCLC, colon 
cancer, ovarian cancer, 
esophageal squamous cell 
carcinoma (ESCC), breast 
cancer, hepatocellular 
carcinoma, basal cell skin 
cancer; correlated with poor 
survival in patients 
(164, 165, 
184–187)  
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PRKCZ (PKCz)  Not known 
Suppresses IL6 
decreasing cell 
proliferation in lung 
cancer model 
Higher levels of PRCKZ or 
PRCKI correlate with delayed 
tumor recurrence in bladder 
cancer; Upregulated in 
hepatocellular carcinoma 
prostate cancer, bladder 
transition cell carcinoma, 
pancreatic ductal cancer, head 
and neck squamous cell 
carcinoma, and breast cancer; 
Correlates with poor survival in 
patients with non-GIST STSs; 
May play a role in breast cancer 
metastasis; Higher levels 
correlates with a better prognosis 
in colorectal cancer patients 
(162, 164, 
165, 185) 
PTEN (PTEN) 
PTEN-/+ mice have 
endometrial 
neoplasia; 
Conditional PTEN 
knockout in the 
endometrium 
causes endometrial 
cancer 
PTEN-/+mice have 
neoplasia in many 
organs Commonly lost tumor suppressor 
 (164, 165, 
188) 
Scrib (Scribble)  Not known 
Loss promotes 
prostate and lung 
cancer formation & 
progression; increased 
Scribble increases 
AKT signaling in 
breast cancer models 
Reduced Scribble correlates with 
invasiveness in cervical cancer; 
increased Scribble increases; 
tumor suppressor in human 
cancers; amplified in many 
human cancers 
(105, 164, 
165) 
Stk11 (Par4/Lkbi) 
 LKB1-/+ mice 
develop 
endometrial 
adenocarcinomas; 
Conditional deletion 
of LKB1 in the 
uterus caused 
completion 
transformation of 
the endometrium 
and highly invasive 
and deadly 
endometrial cancer 
LKB1 deficiency 
promotes breast 
cancer cell invasion; 
LKB1 loss activates 
TGF-b signaling 
angiogenesis; Loss of 
LKB1 expression and 
K-Ras activation 
resulted in melanoma 
formation; LKB1 loss 
increases CSCs; LKB1 
tumor suppressor 
gene mutations cause 
autosomal dominant 
condition, Peutz-
Jeghers 
Implications in NSCLC, ovarian, 
uterine; amplified in pancreatic, 
NEPC, sarcoma, 
cholangiocarcinoma, ACC, MBL, 
Glioma, and GBM; mutated in 
lung, LUAD, cholangiocarcinoma, 
esophagus, bladder, HNC, 
pancreas, and stomach 
(164, 165, 
188–190) 
Table 3 Involvement of Cell Polarity Proteins in Cancer and the Uterus  
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Par3 suppresses breast tumorigenesis through aPKC(138, 185). When 
Par3 is depleted in vivo with a mutated oncogene, such as Notch or Ras6IL, there 
is an increase in metastatic disease caused by an increase in matrix 
metalloproteinase 9 (MMP9) which is important for degrading the extracellular 
matrix (ECM)(138). MMP expression has been associated with increased 
migration and invasion. MMP9 was upregulated through an increase in IL6 
production stimulating Stat3 (Signal Transducer and Activator of Transcription 3) 
signaling(138). This was found to be caused by an overactivation of Pkci that is 
normally controlled by Par3(185). Similarly in skin, Par3 loss (Par3eKO) caused 
a 70% increase in the number of mice with keratoacanthoma, a relatively rare 
tumor in mice(137). Intriguingly, in oncogenic Ras skin cancer mouse models, 
Par3eKO caused a delay in papilloma development and a reduction in tumor 
growth but caused a 12% increase in metastasis of the tumors that were 
observed(137). Since papilloma tumors originate from oncogenic Ras expression 
in keratinocytes while keratoacanthomas are thought to come from the basal and 
suprabasal layers of the epidermis, this study may show a tissue specific function 
of Par3 as either an oncogene or a tumor suppressor(137). In both cases, loss of 
Par3 seemed to stimulate invasion or migration of the cancer cells(137). In 
addition, clear cell renal cell carcinomas with overexpression of Par3 have been 
correlated with a lower survival rate, insinuating that Par3 may be an oncogene 
in renal carcinomas(191). Par3 has been directly tied to tumor progression which 
may be because Par3 interacts with many known tumor suppressors, such as 
PTEN (Phosphatase and Tensin homolog), as well as oncogenes(192, 193). 
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PTEN is most well-known for blocking PI3K (Phosphoinositide 3-Kinase) 
signaling by converting PIP3 (Phosphatidylinositol (3,4,5)-triphosphate) to PIP2 
(Phosphatidylinositol (3,4,5)-diphosphate). PIP3 is necessary for proper 
phosphorylation of AKT (Protein Kinase B), which leads to activation of the PI3K 
pathway. PTEN is a tumor suppressor that is deleted or mutated in a large 
number of cancer types including glioblastomas, breast, prostate, and 
endometrial(194–196). PTEN is also involved in cell polarity through the Par 
complex. A few studies have shown that PTEN and Par3 bind to each other and 
that PTEN can affect proper polarization of mammalian epithelium(130, 131). 
About 43% of all endometrial malignancies have PTEN mutations with more than 
50% of the epithelial-specific tumors being mutated(196). Surprisingly though, 
64% of all endometrial malignancies (75% of epithelial tumors) have PTEN 
protein loss indicating control of PTEN could be through post-translational 
mechanisms(196). While PTEN is mutated in a majority of endometrial cancer 
cases, polarity has not been thoroughly examined within the endometrium.  
 
1.8 Apicobasal Polarity in the Endometrium  
The dynamic nature of the endometrium along with the two forms of 
tubulogenesis (Mullerian duct and endometrial gland), that occurs in uterine 
development imply that cell polarity is highly regulated within the endometrium. 
While, apicobasal polarity has not been examined in cycling mice, glycoproteins 
like Muc1 have been examined in great detail. Muc1 and other mucins are found 
at only the apical lumen of the luminal and glandular epithelium(197). This 
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insinuates some level of apicobasal polarity within the endometrial epithelium. 
During the estrous cycle, Muc1 heavily stains the apical lumen at the highest 
points of estrogen (estrus and proestrus) while the diestrus and metestrus stages 
have decreased staining corresponding with high levels of progesterone(197). It 
appears that proestrus has the most discrete apically localized Muc1(197). Since 
proestrus and estrus represent the most differentiated state, we can postulate 
that these states are when apicobasal polarity and cell adhesion are fully 
established. In addition, endometrial integrins are upregulated during the 
menstrual cycle in humans, where different phases show differing levels of 
integrins(198). This may suggest that different phases of the menstrual cycle 
require a more polarized endometrial epithelium. Since the endometrium is being 
shed (and reabsorbed during estrous), this may be from the reorganization of the 
polarity and adhesion complexes. Interestingly, integrins and Muc1 change 
expression and localization during blastocyst implantation as well(197). 
Implantation is where a majority of polarity related studies have been performed 
in the uterus. In general, to increase uterine receptivity there is a reduction in 
glycoproteins. This reduction in glycoproteins along with an increase in select 
integrins show that polarity is dynamically regulated within the 
endometrium(199).  
Disrupting homeostasis in the endometrium is known for causing diseases 
like endometriosis or endometrial cancer. Homeostasis can be affected by 
disruptions in polarity or polarity regulating proteins like Ezrin(200). Ezrin is an 
ERM (Ezrin-Radixin-Moesin) family member that marks the apical surface and is 
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involved in cortical actin stability(201). An increase in Ezrin expression is 
observed in endometriosis, a disease in which endometrial tissue grows in 
aberrant locations throughout the body, including the ovaries, oviducts, and lining 
of the pelvis(202).  
While no one has looked in depth at how apicobasal polarity affects 
endometrial gland development, DLGH1-/- mice were found to have aberrant 
Mullerian duct development that caused a loss of vaginal tissue and an 
endometrium that is more caudal within the uterus(116). Unfortunately, postnatal 
development of the uterus has not been examined in these mice. Scribble, the 
basal polarity protein, has also been shown to affect Mullerian duct formation 
including a loss of Sox9 expression and thinning of the Mullerian duct compared 
to wild-type mice at E13.5(157). A planar cell polarity protein, Vangl2, can also 
affect the localization of Scribble within the FRT(107). Planar cell polarity is the 
organization of specialized apical structures on cells across the tissue. The 
Vangl2lp mouse exhibits both a mislocalization of Scribble from the basolateral 
membrane but also shortened uterine horns(28). Interestingly, mice 
heterozygous for Vangl2lp generate a significantly reduced number of glands(28). 
Many of the secreted Wnt proteins that cause aglandular phenotypes when 
mutated are thought to be involved in planar cell polarity as well as canonical 
Wnt signaling. These studies with the Vangl2lp PCP mutant mice show that not all 
planar cell polarity proteins are involved in gland development similar to 
Wnt7a(35).  
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Since cell adhesion and cell polarity are intertwined analyzing the data 
from conditional deletion of cell adhesion genes in the uterus may hint at how 
apicobasal will affect endometrial gland development. When E-cadherin 
(Cdh1lox/lox; PR-Cre)  or b-catenin (Ctnnb1lox/lox; PR-Cre), adherens junction 
proteins, are deleted in the mouse endometrium, an aglandular phenotype is 
observed(45, 46). However, in E-cadherin null endometrium, the luminal 
epithelium also looks abnormal and no longer is positive for the common luminal 
epithelium marker, cytokeratin 8(45). This suggests the possibility that glands are 
unable to form because the precursor luminal epithelium does not develop 
properly(45). In addition, the aglandular phenotype observed in b-catenin null 
mice suggests it is more likely canonical Wnt signaling that drives the aglandular 
phenotype(46). Understanding how cell adhesion and cell polarity are involved in 
endometrial development may aid us in determining how the different signaling 
pathways are utilized.  
 
1.9 Cell Adhesion 
Every tissue in the body utilizes cell adhesion in order to properly function and 
communicate with the neighboring cells and environment. Cell adhesion is 
especially well characterized in epithelium, however, it has also been examined 
in cardiomyocytes, endothelial, and Schwann cells(203–205). Epithelial cells 
have junctions at the interface with the extracellular matrix (ECM) and between 
neighboring cells. The adhesions that anchor the cell to the ECM include the 
focal adhesions and the hemidesmosomes. Focal adhesions are regulated by 
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Rho activity and contain numerous proteins including Focal Adhesion Kinase 
(FAK) and Vinculin(206, 207). Hemidesmosomes mediate the attachment of 
intermediate filaments to the cell membrane and are attached to the ECM 
through integrins. Hemidesmosomes are found in a selective number of tissues, 
specifically epithelial tissues, such as the mammary gland or skin.  
On the lateral cell membrane, there are cellular junctions that attach the 
epithelial cells together. This includes tight junctions and adherens junctions in 
the apical domain as well as desmosomes. The desmosomes are similar to 
hemidesmosomes in that they anchor intracellular intermediate filaments to the 
membrane, however the proteins that compose the junctions are different. 
Desmosomes are made of desmogleins, desmocollins, and desmoplakins, while 
hemidesmosomes are composed of integrins(208). The adherens junction 
utilizes two cadherin molecules, one anchored to each cell, that can have either 
homophilic or heterophilic adhesion in the extracellular domain. b-catenin and 
p120 bind directly to the cadherins. b-catenin binding is necessary for proper 
actin binding through a-catenin. These junctions are necessary for the initial 
cell:cell contact and play a role in stabilizing junctions (Figure 3d). There is a 
hierarchy to junction formation. Initially, adherens junctions are formed at the 
point of contact, then desmosomes, and finally tight junctions. Issues with proper 
ordering of junctions has been associated with different diseases like 
inflammatory bowel disease (IBD)(209–211). In addition, there is some evidence 
that adherens junctions have a role in different signaling pathways, which may 
contribute to diseases like IBD. The tight junctions are electrically resistant 
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junctions and necessary for proper barrier formation in most epithelium. Tight 
junctions are composed of multiple transmembrane and scaffolding proteins 
including claudins, occludin, and the zonula occludens (ZO) 1-3.  
My work focuses on the apical junctions consisting of adherens junctions and 
tight junctions (Figure 3c). The apical junctions form as the epithelial cells 
organize and differentiate. Junctional maturation will then occur when the tight 
and adherens junction proteins form discrete and functional junctions (Figure 3d). 
These junctions are necessary for organs to properly work. Deletion of numerous 
genes encoding tight junction proteins exhibit surprising phenotypes. For 
example, ZO-1 deficiency is embryonic lethal for mice by E11.5 and was shown 
to have an angiogenesis defect that leads to an immature yolk sac(212). 
Interestingly, when ZO-1 is lost in the renal podocytes (Tjp1lox/lox, Nphs1-Cre) 
similar to the aPKC mutant mouse, podocyte tight junctions were unable to form 
properly(145, 213). Occludin null mice have normal tight junctions in both 
structure and function in the kidney. Thus we can conclude that Occludin (gene: 
OCLN) is not required for proper tight junction function in the kidney(214). OCLN-
/- mice do exhibit aberrant branching of the gastric glands and male mutants were 
infertile(214). Interestingly, female Occludin null mice were fertile but could not 
suckle their pups(214).  Claudins (gene: CLDN) are necessary for proper tight 
junction formation and when specific Claudins are overexpressed in fibroblasts, 
cells that normally do not have tight junctions, they form tight junction-like 
structures. CLDN11-/- mice no longer have tight junctions in multiple tissues, 
remarkably these mice are still viable(215). Similar to OCLN-/- mice the CLDN11-/- 
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males are sterile but the females breed similar to wild-type mice(215). CLDN1-/- 
mice have an inside-out barrier defect in the epidermis similar to the Par3eKO 
mice(135, 136). 
Adherens junction proteins have been examined a with uterine specific Cre. A 
conditional b-catenin knockout mouse (Ctnnb1lox/lox; PR-Cre) has an endometrial 
aglandular phenotype that was previously discussed in section 1.8 Apicobasal 
Polarity in the Endometrium. Ctnnb1-/- mice are embryonic lethal during 
gastrulation where the ectodermal cell layer is unable to develop(216). Cdh1-/- 
mice are also embryonic lethal due to an inability to form a trophectodermal 
epithelium(217). In addition, a mutation in E-cadherin that disrupts Ca2+ binding 
(Cdh1tm1Cbm/tm1Cbm) are embryonic lethal at a similar stage as the Cdh1-/-, 
potentially showing the lethality is due to loss of adherens junctions(218). 
Conditional loss of E-cadherin in the uterus (Cdh1lox/lox; PR-Cre) causes an 
aglandular phenotype that was previously mentioned in section 1.8 Apicobasal 
Polarity in the Endometrium(45). Cdh1lox/lox; PR-Cre mice do not show 
histological signs of columnar epithelium by P10(45). In addition, these mutants 
showed a loss of b-catenin, a-catenin, and tight junction proteins(45). This loss of 
normal adhesion structures within the epithelium is hypothesized to be the cause 
of the abnormal epithelial architecture(45).  The inherent connection between cell 
polarity and cell:cell adhesion in regulating uterine development and disease 
would indicate that how this connection is modulated would be important in the 
uterus. Curiously, female mice heterozygous for the tumor suppressor Merlin, 
which has been shown to coordinate apicobasal polarity and adhesion, have 
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small litters, but why these mice have reduced litter sizes is not known(219). 
Understanding the role of Merlin in the uterus will help to comprehend how 
polarity and adhesion coordinate regulation of uterine homeostasis. 
 
1.10 Merlin 
Merlin is a tumor suppressor protein that was originally discovered as the 
gene (NF2) mutated in Neurofibromatosis Type 2(220, 221). Merlin is a 
scaffolding protein that links a multitude of other proteins causing it to have a 
wide-variety of functions (Table 4). It is well known for being a negative regulator 
of Hippo signaling in the mammalian brain and liver (Figure 2d)(222, 223). In 
addition, Merlin is necessary for proper junctional maturation and apicobasal 
polarity establishment in epithelial tissues(122). Merlin is a member of the Ezrin-
Radixin-Moesin (ERM) family, but unlike the other ERM family members, Merlin 
is missing the C-terminal actin binding site. Ezrin, Radixin, and Moesin are 
hypothesized to have overlapping functions in different epithelial tissues. 
However, Merlin has been shown to have distinct roles. While initially discovered 
in NF2-associated central nervous system tumors, Merlin has been found to 
affect the development and homeostasis of different mammalian epithelial 
tissues(122, 224, 225). Merlin has a such a wide-variety of functions (Table 4), it 
is pertinent to understand how it affects the female uteri.  
Nf2-/- mice are embryonic lethal by E8.0 because they are unable to 
induce mesodermal differentiation during gastrulation(226). In addition, 
conditionally knocking out Merlin in specific tissues causes aberrant tissue  
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Phenotype Model  Reference 
Hyperproliferation of the eye epithelial cells Drosophila Mer (227) 
Embryonic lethality caused by loss of extraembryonic 
structures Mouse Model (Nf2-/-) (226) 
Increased metastatic disease; Decreased female fertility Mouse Model (Nf2-/+) (219) 
Loss of contact inhibition and mislocalization of b-catenin; 
Unstable adherens junctions; increased pEGFR; inability for 
Merlin to associate with EGFR through NHE-RF1 (normally 
confluency dependent) Nf2-/- MEFs (228, 229) 
Both: Loss of sperm; Testicular atrophy; Increase in 
Lymphomas, chronic hepatitis, and invasive kidney 
adenocarcinoma; Nf2-isoform 2-/- specifically caused delayed 
sensory reactions, signs of axonal neuropathy, irregularly 
shaped axons 
Mouse models 
Nf2-isoform 1-/-; Nf2-
isoform 2-/- (230, 231) 
Increased internalization of EGFR at confluence; Increased 
mechanical tension and myosin II activity 
Liver-derived 
epithelial cells from 
Nf2-/- livers; Caco2 
cells with shNf2 (232) 
Expansion of liver progenitor cells; increased risk of 
cholangiocellular & hepatocellular carcinoma 
Mouse Model 
(Nf2lox/lox; Alb-Cre) (224) 
Fiber cells overproliferate and do not differentiate properly; 
Mislocalization of ZO-1; Multilayering of lens cells with an 
extracellular matrix. 
Mouse Model 
(Nf2lox/lox; Le-Cre) (233) 
Decrease in nerve regeneration; Delayed motor and sensory 
recovery 
Mouse Model 
(Nf2lox/lox; Nefh-Cre) (234) 
Schwann cell hyperplasia and tumors; cataracts and cerebral 
calcifications 
Mouse Model 
(Nf2lox/lox; PO-Cre) (235) 
Schwann cell hyperplasia and tumors; cataracts and cerebral 
calcifications 
Mouse Model (P0-
Sch-D(39-121), 
overexpression) (236) 
Renal intratubular neoplasia at 3 months, hyperproliferative 
and invasive renal carcinoma by 10 months induced by 
aberrant EGFR signaling, inability to stabilize apical junctions 
Mouse Model 
(Nf2lox/lox; Vil-Cre) 
(Nf2lox/lox; Mx1-Cre) (225) 
Required for proper apical junction maturation; Necessary for 
proper apicobasal polarity establishment; Inside-out barrier 
defect; Disorganization and stratification defects of epidermis 
Mouse Model and 
Primary 
Keratinocytes 
(Nf2lox/lox; K14-Cre) (122) 
Mislocalization of Ezrin; misoriented spindles; Multi-lumen 3D 
cultures; aberrant centrosome localization 
shRNA-Nf2 in Caco2 
cells; Mouse models 
(Nf2lox/lox; K14-Cre, 
Nf2lox/lox; Vil-
CreERT2,  (237) 
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Loss of hair follicle planar cell polarity; Improper development 
of the bulge stem cell; Decrease in Sox9 expression  
Mouse Model 
(Nf2lox/lox; K14-Cre) (238) 
Table 4 Functions of Merlin in different tissues 
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morphogenesis and homeostasis. In the liver, when Merlin is lost (Nf2lox/lox; Alb-
Cre hereafter referred to as Nf2LKO), it causes an overgrowth of the liver oval 
cells (OCs), without causing any phenotypes in the hepatocytes and this was 
shown to be caused by an overactivation of EGFR signaling(224). Nf2LKO mice 
also exhibit hepatocellular carcinoma and cholangiocarcinoma if they survive to 
adulthood(224). Interestingly, while OCs were determined to be the source of the 
tumors, different labs observe EGFR or Hippo signaling as the main cause of 
tumorigenesis(223, 224). The tumorigenic properties of Merlin have been 
observed in other mutants as well. Nf2+/- mice have a high frequency of 
osteosarcomas as well as a higher number of hepatocellular carcinomas that 
metastasize(219). This was different than humans, who are hemizygous for Nf2, 
that commonly get vestibular schwannomas(239). Merlin loss in the kidney 
(Nf2lox/lox; Vil-Cre) causes invasive renal carcinomas by 6 months of age(225). 
These tumors had a decrease in junction and polarity markers similar to affects 
observed in the skin(122, 225). In the skin, Merlin was determined to be 
necessary for proper recruitment of Par3 to the primitive apical junction before 
junctional maturation(122). Loss of Merlin in the basal cells of the epidermis 
(Nf2lox/lox; K14-Cre hereafter referred to as Nf2skinKO) causes an inside-out 
barrier defect like other cell adhesion and polarity mutant mice(122, 135, 136). 
Nf2skinKO mice also exhibit abnormal skin morphology from aberrant 
asymmetric divisions of the basal cells(122).  Merlin deficiency in Schwann cells 
produces a loss of contact inhibition which is instigated by increases in canonical 
Wnt signaling(240). Merlin inhibition of canonical Wnt signaling is also observed 
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in pancreatic cancer cell lines(53). However, it appears that how Merlin affects 
Wnt signaling is tissue dependent (Figure 2c)(53, 241–243). Merlin is involved in 
many signaling pathways because of the proteins it is able to bind to and 
indirectly regulate. A Merlin binding partner, NHE-RF (Na+/H+ Exchanger 
Regulatory Factor), is found to localize to the apical lumen of the endometrium at 
specific times during the menstrual cycle and is hypothesized to be important in 
estrogen signaling and proliferation(244). Merlin has been found to affect the 
localization of the membrane-bound receptor, Notch, in Drosophila(80). In 
addition, Notch signaling has been shown to be regulated during the menstrual 
cycle(245). Merlin may play an important role in endometrial development and 
homeostasis through the different proteins and pathways it interacts with(80, 122, 
246, 247).  
 
1.11 Dissertation Summary 
This dissertation examines how Merlin and apicobasal polarity affect 
endometrial development and endometrial cancer. We find that Merlin is 
necessary for proper endometrial gland formation. In addition, Merlin may be 
important in Mullerian duct polarized migration. We determined that conditional 
loss of Merlin within the endometrium causes a mislocalization of polarity 
proteins and infertility through changes in F-actin that may facilitate the decrease 
observed in Wnt signaling. Furthermore, Merlin is necessary for proper 
endometrial homeostasis during aging. In addition, we have established that 
apicobasal polarity is lost in endometrial cancer and polarity loss causes changes 
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in compartmentalization of the membrane-receptor, Notch. Finally, we observed 
that Notch signaling plays a role in polarity induced proliferation and migration 
changes in endometrial cancer cell lines.  
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Chapter 2: Materials & Methods 
This chapter is modified from Williams, E., Villar-Prados, A., Broaddus, R., 
Gladden, A. (2017) Loss of polarity alters proliferation and differentiation in low-
grade endometrial cancers by disrupting Notch signaling. PLoS ONE 12 (12): 
e0189081. https://doi.org/ 10.1371/journal.pone.0189081 is licensed under CC 
BY (Creative Commons Attribution license) by PLoS One. 
 
2.1 Mouse Strains 
We generated both the Nf2lox/lox; Wnt7a-Cre and the Nf2lox/lox; PR-Cre 
mouse lines by crossing the previously generated Nf2lox/lox mice with either 
Wnt7a-Cre mice or PR-Cre mice(248–250). When crossing, Cre was paternally 
contributed and control mice were either Nf2lox/lox, Nf2lox/wt; -Cre as heterozygous 
deletion showed no phenotype in the uterus. Mice were maintained on a mixed 
FVB, C57BL/6 background. The MD Anderson Cancer Center Institutional 
Animal Care and Use Committee (IACUC) approved all animal procedures. Mice 
were bred to generate homozygous female mutants.  
2.11 Fecundity Study 
Six wild-type (Nf2lox/lox, Nf2lox/wt; PR-Cre, Nf2lox/wt; Wnt7a-Cre) and 6 
Nf2lox/lox; PR-Cre mice were mated for 3 months. Mice were examined for plugs 
every morning. After mice were plugged, weight was taken at E0.5 and then 
again at E7.5 until mice were at E14.5. Nf2lox/lox; PR-Cre mice did plug but did not 
gain weight while wild-type mice would start to increase in weight around E7.5. 
Females were left with males during the entire 3 months and litters were counted 
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for number of pups. 3.5 DPC uteri were obtained from mice, 3 days after vaginal 
plugs were observed.  
 
2.2 Immunohistochemistry 
Use of human tissues was approved by the IRB of the University of Texas 
MD Anderson Cancer Center (LAB1-718) (PI: Broaddus). Informed written 
consent was obtained through the MD Anderson Cancer Center “Front Door” 
tissue banking consent policy (LAB03-0320).  All authors received training on 
working with and the ethics of human specimen research from MD Anderson 
Cancer Center.  De-identified primary human endometrial tissue samples were 
obtained from the tissue bio-specimen and pathology core facility at MD 
Anderson Cancer Center. Frozen endometrial tissue sections were immediately 
fixed in 4% paraformaldehyde/PBS for 20 minutes at room temperature. Samples 
were permeabilized using 0.5% Triton in PBS for 15 minutes at room 
temperature and then blocked for 30 minutes in blocking buffer containing 10% 
fetal bovine serum (FBS) and 1% bovine serum albumin (BSA) diluted in PBS-
0.01% Tween 20 (PBST). Sections were subsequently incubated with the 
following primary antibodies: Par3 (1:500, rabbit, Millipore, 07-330), Ezrin (1:500, 
mouse, Invitrogen, 3C12), E-cadherin (1:1000, mouse, BD, 610182), Acetylated 
Tubulin (1:1000, mouse, Sigma, T6793), ZO-1 (1:500, rabbit, Invitrogen, 61-
7300), Notch1 (1:500, rabbit, Cell signaling, D1E11), Notch2 (1:750, rabbit, Cell 
signaling, D76A6), Pan Cytokeratin (1:500, rabbit, Abcam, PA5-21985), c-Myc 
(1:250, mouse, Santa Cruz, sc-40), and Pericentrin (1:1000, rabbit, Abcam, 
 51 
ab4448) overnight at 4°C. Slides were then washed three times in PBST and 
incubated with secondary antibodies CY3 Rabbit (1:200, Jackson 
Immunoresearch), Alexa 488 Mouse (1:200, Jackson Immunoresearch), 
Phalloidin CY5 (1:250, Invitrogen), and 4’6’-diamidino-2-phenylindole 
(DAPI,1:1000). Slides were washed two times in PBST, one time in PBS and 
mounted with Vectashield (Vector Laboratories). 
Staining of MDCK 3D cultures was adapted from previous descriptions 
(237, 251), briefly, cultures were fixed in 3.7% Formalin in cytoskeletal buffer 
(10mM 2-(N-morpholino)-ethanesulfonic acid sodium salt (MES) pH 6.1, 138 mM 
KCl, 3mM MgCl2, 2mM EGTA) for 20 minutes at room temperature. Washed in 
PBS and then permeabilized in 0.5% Triton/PBS for 20 minutes at room 
temperature. Cultures were then washed in PBS and subsequently washed with 
100mM Glycine/PBS for 15 minutes, 3 times. Cultures were blocked for 1 hour in 
PBST/0.2% Triton/1% BSA/10% FBS and then left overnight at room 
temperature with primary antibodies in blocking buffer. The MDCK cell culture 
was washed in PBST 3 times for 20 minutes and then incubated in blocking 
buffer with secondary antibodies for 1 hour at room temperature.  
All mouse tissue was fixed in either 3.7% Formalin or 4% PFA in PBS. 
Tissue was then either processed for paraffin-embedding (McCormick Scientific) 
or OCT-embedding (Fischer Healthcare). H&E staining: Paraffin-embedded 
samples were heated to 55°C for 20 minutes. Samples were incubated in 
histoclear (3x) for 10 minutes each. Samples were progressively hydrated in 
(100% (x2), 95% (x2), and 70% EtOH) ethanol and then deionized water for 22 
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minutes. Samples were stained with Harris Hematoxylin modified (StatLab) for 7 
minutes followed by washing in EtOH Acid (1% HCl in 70% EtOH) and bluing in 
0.1% Sodium Bicarbonate. Samples were stained with 0.5% eosin Y (Sigma 
Aldrich) for 5 seconds before being washed in 4x 100% EtOH. Samples were 
incubated in HIstoclear (3x, 10 minutes) before being mounted with Permount 
(Fischer). BrdU and Foxa2 staining: All mice were pulsed with BrdU (100µg per 
gram of body weight) for 2 hours before being sacrificed. OCT-embedded 
samples were thawed and dried for 10 minutes. Samples were then washed in 
PBS 2x for 30 minutes each and permeabilized in 0.5% Triton/PBS for 20 
minutes at room temperature. Samples were then washed in PBS, 3 times before 
incubated in 1.5N HCl in PBS for 10 minutes. Slides were washed three times in 
PBS. Samples were blocked for 1 hour in PBST/10% FBS and then left overnight 
at room temperature with primary antibodies (BrdU [1:200, mouse, abcam, 
ab6326]; Cleaved Caspase 3 [1:400, rabbit, Cell Signaling, Asp175] or Par3 
[1:500, rabbit, Millipore, 07-330], FoxA2 [1:2000, rat, Seven Hills 
BioReagents,WRAB-1200], b-catenin [1:1000, mouse, BD, 610153]) in blocking 
buffer. The mouse tissue samples were washed in PBST 3 times for 20 minutes 
and then incubated in blocking buffer with secondary antibodies for 1 hour at 
room temperature. Other immunofluorescent stainings: OCT-embedded samples 
were thawed and dried for 10 minutes. Samples were then hydrated in PBS 2x 
for 30 minutes each and permeabilized in 0.5% Triton/PBS for 20 minutes at 
room temperature. Samples were then washed in PBS. Samples were blocked 
for 1 hour in PBST/10% FBS/1% BSA and then left overnight at room 
 53 
temperature with primary antibodies (Sox9 [1:250, rabbit, Santa Cruz, sc-20095]; 
E-cadherin [1:1000, mouse, BD, 610182], Par3 [1:500, rabbit, Millipore, 07-330], 
ZO-1 [1:500, rabbit, Invitrogen, 61-7300], Muc1 [1:100, rabbit, Dan Carson’s 
Laboratory(252)], Foxa2 [1:2000, rat, Seven Hills BioReagents,WRAB-1200], 
Vinculin [1:300, mouse, Millipore, MAB3574], Myosin IIB [1:500, rabbit, 
Biolegend, 909901], Rho [1:100, mouse, Santa Cruz, sc-418], pMLC [1:500, 
rabbit, abcam, ab2480], b-catenin  [1:1000, mouse, BD, 610153], Merlin [1:100, 
rabbit, Santa Cruz, sc-331],  P-cadherin [1:200, rat, Takara, M109], Yap [1:300, 
mouse, Cell Signaling, 4912]) in blocking buffer. The mouse tissue samples were 
washed in PBST 3 times for 20 minutes and then incubated in blocking buffer 
with secondary antibodies, smooth muscle actin-Cy3 (1:200, mouse, Sigma, 
C6198, SMA), or Phallioidin Cy3 (1:200, Invitrogen, A12380) for 1 hour at room 
temperature. All samples were mounted with Fluoromount-G (Southern Biotech, 
0100-01). All tissue samples and cells labeled were visualized using a Nikon A1 
laser scanning confocal microscope. 
 
2.3 Cell culture and reagents 
Madin-Darby Canine Kidney (MDCK) cell lines and endometrial cancer 
cell lines were cultured in Dulbecco’s Modified Eagle’s Medium (DMEM) with 
10% fetal bovine serum (FBS). Generation of knockdown MDCK cell lines is 
described below. Knockdown MDCK cells were selected for with puromycin 
(0.7µg/mL). Re-expression cell lines were selected for with hygromycin (3µg/mL). 
The g-secretase inhibitor DAPT (Sigma) was placed on cells at a concentration 
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of 1 µg/ml in new media added with fresh DAPT every 24 hours for 48 hours for 
BRDU and expression experiments and up to 72 hours for migration 
experiments. Primary endometrial epithelial cells was isolated by a protocol 
adapted from Eritja et al(253). Cells were isolated at P60 from Nf2lox/lox females 
and kept in DMEM/F12 (Sigma, D8062) supplemented with 1% 
antibiotics/antimycoctics (Sigma, A5965) and 1mmol/L Hepes (Corning cellgro, 
25-060-Cl). Ad5CMVCre-eGFP (Adenovirus cre) was added at 80-90% 
confluency at a concentration of 100 MOI/cell. Cells were incubated for 24 hours 
in adenovirus cre before media was changed. Cells were fixed within 72 hours.   
2.31 3D culture assay 
MDCK 3D cyst formation was modified from previously described 
work(254). In short, an 8-well chamber slide was pre-coated with a collagen 
mixture (24uM Glutamine, 2.35mg/mL NaHCO3, 1x MEM, 20mM Hepes, 2mg/mL 
Collagen I). MDCK cells were suspended in the same collagen mixture at a 
concentration of 3x104. DMEM with 10% FBS was added 45 minutes after 
placing the chamber slide in the 37°C incubator. The DMEM media was changed 
every 2-3 days without disturbing the matrix/cell layer.  
2.32 Generation of knockdown MDCK cell lines 
Virus was produced by transfecting HEK293T cells at 80-90% confluency 
with the pLK0.1 lentiviral expression vector obtained from Open biosystems 
(Par3 kd clone ID: TRCN0000118134 and Ezrin kd clone ID: TRCN0000062462, 
Table 5), Scr-shRNA and Nf2 kd shRNA in the pLK0.1 vector obtained from the 
McClatchey lab (Table 5)(255). In addition, packaging vectors (VSVG and ΔVPR) 
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were utilized. MDCK cells were infected with the virus and polybrene (1µg/mL) in 
DMEM with 10% FBS. The following day, new media was added with puromycin 
(0.7µg/mL) for selection. Knockdown was verified by Western blots.  
2.33 Generation of primary knockout endometrial cell lines 
Adenovirus cre was utilized to infect Nf2lox/lox endometrial epithelium. 
Endometrial cells were infected with the virus in DMEM with 10% FBS. The 
following day, new media was added. Knockout was verified by PCR.  
2.34 Generation of overexpression endometrial cancer cell lines 
The day before the transfection, cells were plated at 2x105 on each well of 
a 6-well dish. Par3-myc was transfected in when the cells reached 50-70% 
confluency using Lipofectamine LTX (Invitrogen) and Plus Reagent (Invitrogen). 
The Par3-myc construct was a gifr from Iam Macara (Addgene plasmid #19388) 
and has been previously described(256). 24 hours post-transfection, fresh media 
was put on cells. Cells were fixed 48 hours after original transfection.  
2.4 Quantitative RT-PCR 
For Human Endometrial Tissue Samples: The qRT-PCR was performed 
as indicated by Schlumbrecht et al(257).  For MDCK cells, endometrial cancer 
cells, and isolated endometrium: RNA was extracted by treating cells or tissue 
with Trizol and chloroform. RNA was purified with 100% isopropanol and 75% 
ethanol. RNA pellets were dissolved in 30-50uL of DEPC water at 55°C. RNA 
purity was confirmed by nanodrop to have a A260/A280 ratio greater than 1.8. 
cDNA was synthesized using a SuperScript First-Strand Synthesis kit. The cDNA 
was analyzed using SYBR green quantification with the 7900HT Sequence   
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Name Sequence 
Par3 kd 8134  5’-ATCATAAGATTTGTCGATGGC-3’ 
Par3 kd 8135  5’-TATCATAAGATTTGTCGATGG-3’ 
Ezrin kd  5’-TTTATTATCCACATAGTGGAG-3’ 
Nf2 kd  5’-GAGGAAGCAACCCAAGACGTT-3’ 
Scr-shRNA 5’-CAGTCGCGTTTGCGACTGG-3’ 
Table 5 shRNA oligos for MDCK cells and endometrial cancer cell lines. 
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Detection System (Applied Systems). Primers used are found in the table, (Table 
6). Samples were assayed in triplicate. Data were normalized to HPRT. Samples 
below the limit of quantification were not included. The fold change of the DCT 
compared to HPRT was utilized for analysis (2-DCT). For Isolated Endometrium: 
Uteri were extracted and placed in Trizol. Samples were frozen until genotyping 
was complete. Tissue was broken up using a cryogenic mortar and pestle. A 
similar protocol to MDCK cells was utilized to isolate RNA and run qRT-PCR.  
 
2.5 Cell extract preparation and Western blotting 
For Western blots, cells were scraped off culture dishes and suspended in 
Triton lysis buffer (1% Triton X-100, 50mM Tris-HCl pH 7.4, 140mM NaCl, 1mM 
EDTA, 1mM EGTA, 1mM PMSF, 1mM Na3VO4, 1mM sodium fluoride, 1mM β-
glycerophosphate, 10µg/mL aprotinin, 10µg/mL leupeptin) followed by sonication.  
Cell lysates were then centrifugation and the debris was removed. Bradford 
assays were used to quantify the amount of proteins. Cell lysates (30µg) were 
loaded onto SDS-PAGE gels and transferred to a PVDF membrane. Membrane 
blots blocked for at least 1 hour in 5% milk in TBST. Primary antibody was added 
overnight at 4°C. Primary antibodies include: (1:500, rabbit, Cell signaling, 
D1E11), Notch2 (1:750, rabbit, Cell signaling, D76A6), Par3 (1:750, rabbit, 
Millipore, 07-330), Ezrin (1:1000, mouse, Invitrogen, 3C12), Notch1 PTEN 
(1:1000, rabbit, Cell Signaling, 138G6), Merlin (1:400, rabbit, Santa Cruz, sc-332) 
and β-tubulin (1:1000, Sigma/Santa Cruz, T7816/sc-9104). Secondary antibodies 
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Name F/R Sequence 
b Actin 
F 5’-CTAAGGCCAACCGTGAAAAG-3’ 
R 3’-ACCAGAGGCATACAGGGACA-5’ 
GAPDH F CCCTTCATTGACCTCAACTACA 
 R ATGACAAGCTTCCCGTTCTC 
HPRT F AGCTTGCTGGTGAAAAGGAC 
 R TTATAGTCAAGGGCATATCC 
h-HPRT F TTCTGTGGCCATCTGCTTAG 
 R GTTTAGGAATGCAGCAACTGAC 
Notch1 -1 
F CAGCCCTTGTCTCCAGAATG 
R TTGGCACCGTTCTTACAGG 
Notch1 -2 
F GGATGGCATCAATAGCTTCATG 
R CCAGGGTCACAGTCACATTTG 
Notch2 -1 
F TCGGGATAGCTATGAGCCCT 
R GGCATGTTGCTTTCCCCAAC 
Notch2 -2 
F ATTTCATGCAGGTTAGAGAAGGAC 
R CTGTCTGAGAGCTCAGTGACCTTA 
Notch3 -1 
F ATCAACCGCTATGACTGTGTC 
R TCCATTTTCCCCATCCACG 
Notch3 -2 
F GCTGCGAAACTGATGTCAAC 
R GCTACTCTGACACTCATCCATG 
Notch4 -1 
F AGTAACCCCTCAAACACAGC 
R ACAAATCCACACCCATCACC 
Notch4 -2 
F GGTAAACCCATGTGAGTCCAG 
R AGTTCTGTCCATTGTAGCCTG 
JAG1 -1 
F GAAAGTGCCCAGAGCCTAAA 
R CAGGACAGCTGAAGAACTGAA 
JAG1 -2 
F GAACCTGATTGCGAGCTACTAC 
R GGTGGACAGATACAGCGATAAC 
JAG2 -1 
F GGACGCCAATGAATGTGAAG 
R CGGGATGCAGAGACAGTAATAG 
JAG2 -2 
F ACCTGATTGGTGGCTATTACTG 
R CTGCCCATGACAGTCGTTTA 
DLL1 -1 F CCGATGACCTCACAACAGAAA 
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R CACACGAAGCGGTAGGAATAC 
DLL1 -2 
F GCAGATCAAGAACACCAACAAG 
R GTCCAAAGGACAGCAAGA 
DLL3 -1 
F GAATCACCCTGAAGATGGAGAC 
R GCTCCAAAGGACAGCAAGA 
DLL3 -2 
F CGGATGGACCTTGCTTCAAT 
R ACAGTTGGAGCCTTGGAATC 
DLL4 -1 
F GCTCAAGAACACAAACCAGAAG 
R GGGCCAGATTATAGTCCAATGT 
DLL4 -2 
F TCCACTGGCATCTGTGTTTC 
R CCTCCTCTCTCCTCTCTGATTT 
P21 -1 
F CATCCTGGCCTGTACTGTT 
R CTTGCCCTTCAGAGGCTTATAG 
P21 -2 
F AGCTGAACAAGGAGTCAGATG 
R CAGGGCCAGAAGAGACAATAA 
HeyL -1 
F AGTTGATCTTGGGTTCACTCTC 
R ACCAGAAAGGCTTGGGAATAG 
HeyL -2 
F GTTCTTCATCCAGGGAGCTCTAAA 
R GAGGAAGATGCCTTCACAGATAG 
Hey1 -1 
F GCTATGGACTATCGGAGTTTGG 
R CTGGGAGGCGTAGTTGTTAAG 
Hey1 -2 
F GCCCGATATCTGAGCATCATT 
R CGTAGTTGTTAAGGTGGGAGAC 
Hey2 -1 
F GCGGCGAGATCGGATAAATAA 
R TGATCTACCGTCATTTGCAGTAT 
Hey2 -2 
F AACATCTCAGATTATGGCAAGAAAG 
R CCAGTCGTCTCAACTCAGATAAA 
Hes6 -1 
F AAAGCGCGCCTAGACAAA 
R CCGTCTGGTCTTGTAACTTGAT 
Hes6 -2 
F CCAACACCTGTCGCTCTT 
R CTTGTAACTTGATGCCCATGAC 
Ccnd1 -1 
F GCCCTCCGTATCTTACTTCAAG 
R GCGGTCCAGGTAGTTCATG 
Ccnd1 -2 
F CATCTACACTGACAACTCTATCCG 
R TCTGGCATTTTGGAGAGGAAG 
Myc -1 F GCTGTTTGAAGGCTGGATTTC 
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R GATGAAATAGGGCTGTACGGAG 
Myc -2 
F CGATTCCACGGCCTTCTC 
R TCTTCCTCATCTTCTTGCTCTTC 
Sox9 -1 
F CAAGACTCTGGGCAAGCTC 
R GGGCTGGTACTTGTAATCGG 
Sox9 -2 
F GCCGACTCCCCACATTC 
R CGCTTCAGATCAACTTTGCC 
Sox17 -1 
F CGATGAACGCCTTTATGGTG 
R TTCTCTGCCAAGGTCAACG 
Sox17 -2 
F AATATGGCCCACTCACACTG 
R TTTCTCTGTCTTCCCTGTCTTG 
Wnt7a -1 
F ACGAGTGTCAGTTTCAGTTCC 
R AATCGCATAGGTGAAGGCAG 
Wnt7a -2 
F TTACACAATAACGAGGCGGG 
R TTGTCCTTGAGCACGTAGC 
Hoxa11 -1 
F AGGAGAAGGAGCGACGG 
R GGTATTTGGTATAAGGGCAGCG 
Hoxa11 -2 
F CTAAACTAGCATCCCTACCCTG 
R ATCAGTTCTTGCCTCTTCCG 
Birc2 
F  GAAGAAAATGCTGACCCTACAGA 
R  GCTCATCATGACGACATCTTTC 
Birc3 
F  AGAGAGGAGCAGATGGAGCA 
R  TTTGTTCTTCCGGATTAGTGC 
CTGF 
F  GGGCCTCTTCTGCGATTTC 
R  ATCCAGGCAAGTGCATTGGTA 
Merlin -1 
F CTCCTGCATACCTGCATATCTC 
R CTAAGCCAGTCCACACTTCTAC 
Merlin -2 
F CAGGGAAGAGAAGGCTAGAAAG 
R ATTGGGTTCATGGGTGGATAG 
Table 6 qRT-PCR primers for MDCK cells, endometrial cancer cells, and isolated 
endometriums  
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were put on the next day for at least 30 minutes. Protein expression was 
depicted using enhanced chemiluminescence on a LiCor machine. 
  
2.6 Image processing, analysis, and densitometry 
All tissue samples and cells were visualized using a Nikon A1 laser 
scanning confocal microscope or a Nikon 80i upright Fluorescent Microscope. 
Images were processed using the Nikon-Elements software (Nikon). Quantitative 
analysis of endometrial tumor samples was performed blind by an independent 
investigator. Quantitative analysis of the mouse tissue including myometrium, cell 
adhesion angles, BrdU, and Cleaved Caspase 3 (CC3) calculations was 
performed utilizing ImageJ. Line intensity plots (Phalloidin, pMLC, [Vinculin, 
Myosin IIB], Sox9, [P-cadherin, E-cadherin], Muc1, and FoxA2 were also 
performed on ImageJ analysis. Densitometry was performed by Image Studios 
Version 3.1 using the data from the LiCor machine.  
 
2.7 Statistics 
The quantitative data in this dissertation was analyzed utilizing either two-
tailed Student’s t-test or ANOVA. Data that was found to be significant was 
marked with some form of an asterisk and discussed in figure legeneds. Data 
was considered significant if P<0.05.  
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Chapter 3: Merlin regulates endometrial gland development through 
polarized signals.  
 
3.1 Introduction 
Female infertility is a complex problem that is still not well understood. In 
the United States, 17% of women need infertility assistance(258, 259). In a 
multitude of animal models the endometrium has been found to be a common 
cause of impaired fertility, specifically when endometrial glands are lost. The 
endometrium is composed of stromal cells that surround the luminal and 
glandular epithelium. The luminal epithelium, the epithelium surrounding the 
uterine cavity, gives rise to glandular epithelium that invaginates into the stroma 
after birth. The glandular epithelium is hypothesized to secrete mucins to protect 
the uterus from infection and histrophs to facilitate proper uterine and blastocyst 
response during pregnancy(197, 260).  
 Endometrial glands are observed in mouse models to be necessary for 
protein secretion correlated with successful implantation as well as a source of 
nutrients as the placenta is generated(17, 18, 261). Data examining fertile and 
infertile women demonstrated that increased plasma levels of Interleukin 1b and 
Tumor Necrosis Factor were predictive of a successful implant in women 
undergoing in vitro fertilization(262, 263). Examining how the endometrial glands 
form may lead to a better understanding of how female infertility arises and can 
be potentially treated.  
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Endometrial glands are formed through a process called tubulogenesis 
that occurs postnatally in both mice and humans. There are many methods of 
tubulogenesis that have previously been reviewed but endometrial glands are 
thought to go through a budding process(264). At postnatal day 0 (P0) in mice 
the endometrium has only the central lumen of epithelial cells. Beginning at P5, 
small invaginations begin to form off the main luminal epithelium and buds start 
to develop at P7(265). At P8 a portion of the buds begin to extend and form 
structures resembling teardrops(19). At P11, elongation of the initial buds and 
teardrops begin to rotate forming a more complex, spiral shape gland by 
P21(19). Following the onset of puberty around P60, a gland will consist of 
branched structures coming off of a main stem (Figure 1d)(20). Development of 
the endometrial gland involves both Wnt and Notch signaling, however, what how 
these pathways regulate elongation or branching is still not known. There are 
many genes that have been associated with gland formation through information 
obtained from different mouse models manipulating genes including FoxA2, b-
catenin, and Notch1 (Table 1)(21, 26, 46). While the molecular mechanisms 
underlying endometrial gland development have begun to be examined, there 
are still many unanswered questions that could help us understand both 
endometrial gland formation and infertility.  
Endometrial gland formation takes a collaboration between cell adhesion 
and apicobasal polarity to properly form glandular architecture. Without proper 
cell adhesion, the epithelium would not hold together to form the discrete 
structures as is shown when E-cadherin is deleted from the endometrium(45). 
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Without cell polarity, polarized migration and cell adhesion do not properly 
function. In order to understand how apicobasal polarity and cell adhesion are 
involved in endometrial gland formation, we examine a protein that is known to 
couple proper apical junction maturation and polarity establishment, Merlin. 
Originally discovered for its role in Neurofibromatosis Type 2, a benign tumor 
disease, it has since been shown in vivo to be important for the development and 
homeostasis of epithelial tissues including the skin, kidney, and liver(122, 224, 
225). Nf2-/+ mice were found to be sub-fertile however why these mice have 
reduced fertility is not known(219). Utilizing endometrium specific Merlin 
knockout mice, we were able to determine the role of Merlin during endometrial 
development and how it may lead to infertility. 
 
3.2 Results 
3.21 Merlin deletion causes loss of gland formation and female infertility. 
 Conditional loss of Merlin in endometrial epithelium (Nf2lox/lox; Wnt7a-cre; 
Nf2eeKO) or in the endometrial epithelium and stroma (Nf2lox/lox; PR-cre; 
Nf2seeKO) causes a loss of endometrial glands before puberty at P21 and is not 
due to a delay in gland formation as no glands are observed during estrus at P60 
(Figure 4a-e, not shown). Wild-type mice at P21 have an average of 8-10 
endometrial gland cross sections per uterine section, while Merlin null mice have 
less than one (Figure 4f-g). 
  Since endometrial glands are necessary for proper female fertility, we 
examined whether fertility was intact. We performed a fecundity study over 3   
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Figure 4 Merlin loss in the endometrium causes a loss of glands. 
Wild-type (a) and Nf2lox/lox; Wnt7a-Cre (Nf2eeKO, b) H&E staining show the loss of 
glands on the Nf2eeKO uteri. Magnification of the wild-type (c) glandular epithelium, (d) 
luminal epithelium and the Nf2eeKO (e) luminal epithelium. Quantifications of the 
number of glands observed in a cross-section of wild-type and Nf2eeKO mice (f, n=13) 
or wild-type and Nf2lox/lox; PR-Cre mice (Nf2seeKO, g, n=3). A table summarizing the -
data obtained from a 3-month fecundity study with the Nf2seeKO mice (h). 
Quantifications of the number of litters a single mouse had (i) or the average number of 
pups per litter (j) within the fecundity study. 
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months where 6 Nf2seeKO mutants and 6 wild-type female mice were mated to 
wild-type male mice. The 6 wild-type mice on average had 3 litters with 7 pups 
per litter, while the Nf2seeKO mice did not have any litters (Figure 4h-j). 
Vaginal plugs were observed in the Nf2seeKO mice similar to wild-type 
littermates suggesting mating and estrus is normal in the female mice. Weight 
was examined after plugs were observed. Wild- type mice showed increases in 
weight around E7.5. Nf2seeKO mice never gained weight during the normal 
gestation period of 19 days. This suggests that the pregnancy is lost before E7.5 
and that Nf2 mutant female mice are infertile. 
In addition to fertility, endometrial glands have distinct markers from the 
luminal epithelium. Previous studies have shown that wild-type endometrial 
glands have nuclear Sox9 staining and we observe similar results that is 
quantitated by a line plot (Figure 5a, g, white line denotes line quantitation)(22). 
We also examined nuclear Sox9 in Nf2eeKO and Nf2seeKO endometrial 
epithelium and found the luminal epithelium had a similar intensity of Sox9 as the 
wild-type luminal epithelium (Figure 5a-c, g). Additionally, another endometrial 
gland marker, FoxA2(21), was not found in the majority of Nf2eeKO or Nf2seeKO 
endometrial epithelium, while the wild-type mice had intense FoxA2 nuclear 
staining in the glandular epithelium (Figure 5i-m). The Nf2eeKO and Nf2seeKO 
luminal epithelium did exhibit some nuclear FoxA2 at discrete locations, 
specifically near curves in the luminal epithelium (Figure 5k-l) that had a similar 
intensity to the glandular epithelium of the wild-type tissue (Figure 5i, k, l, n). A  
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Figure 5 Endometrial Gland Markers within the Nf2eeKO and Nf2seeKO mice at 
P21.  
Sox9 was examined in wild-type (a, a’), Nf2eeKO (b, b’), and Nf2seeKO (c, c’) mice. 
Muc1 was examined in wild-type (d, d’), Nf2eeKO (e, e’), and Nf2seeKO (f, f’) mice. The 
line intensity of Sox9 in wild-type glandular epithelium, as well as, wild-type, Nf2eeKO, 
and Nf2seeKO luminal epithelium compared, the left area of the line represents the 
basal boundary of the cell (g). The line intensity of Muc1 staining in wild-type glandular 
and luminal epithelium compared to Nf2eeKO and Nf2seeKO luminal Muc1 staining (h). 
FoxA2 staining in wild-type endometrial glands (i, i’), wild-type (j, j’), Nf2eeKO (k, k’), 
and Nf2seeKO (l, l’) luminal epithelium. Line plots of FoxA2 intensity in wild-type 
glandular epithelium compared to wild-type, Nf2eeKO, and Nf2seeKO luminal epithelial 
cell (m), left region of line plot is the basal boundary of the cell. Line intensity of FoxA2 in 
wild-type endometrial glands compared to Nf2eeKO and Nf2seeKO luminal epithelium 
(n). Immunofluorescence images of SMA (smooth muscle actin) in wild-type (o, o’), 
Nf2eeKO (p, p’) and Nf2seeKO (q, q’) uteri. Quantification of the density of the outer 
radial myometrium (n=3, r). Quantification of the density of the inner longitudinal 
myometrium (n=3, s). Quantification of the length of longitudinal nuclei (n=3, t). *P<0.05 
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similar phenotype was observed with Sox9 in some samples of Nf2eeKO and 
Nf2seeKO luminal epithelium though not as consistent (not shown). 
Endometrial glands are hypothesized to secrete more mucins than the 
endometrial luminal epithelium. Thus, we were interested if Muc1 decreased in 
the endometrium of our Nf2 mutant mice. We observed that the wild-type mice 
exhibited a higher intensity of Muc1 staining in the glandular epithelium then in 
the luminal epithelium (Figure 5d, h).  Compared to wild-type luminal epithelial 
cells, Nf2seeKO and Nf2eeKO luminal epithelium showed increased Muc1 
staining on portions of the epithelium (Figure 5d-f, h). Interestingly, these 
Nf2eeKO and Nf2seeKO luminal Muc1 stainings, were a similar intensity as the 
glandular staining of the wild-type mice (Figure 5h). These increases in glandular 
markers provide evidence that the mutant luminal epithelium is capable of 
differentiating into glandular epithelium but is unable to assemble the glandular 
architecture. 
The endometrium is known to be necessary for proper myometrium 
development(266). Given the alterations in glandular architecture in the Nf2-
deficient endometrium, we were interested in how the myometrium was affected 
in the Nf2eeKO and Nf2seeKO uteri. To examine the myometrium, we stained for 
smooth muscle using SMA (smooth muscle actin) and found that at P21, the 
longitudinal and radial SMA populations look relatively similar between the wild-
type and mutant mice (Figure 5o-q). When examined closely, we determine the 
number of nuclei increased in the outer, radial myometrium compared to wild-
type mice (Figure 5r). Similarly, the inner, longitudinal cells showed a slight 
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increase in nuclei density compared to the wild-type myometrium (Figure 5s). In 
both myometrial cell types the Nf2eeKO mice showed the highest density of cells 
compared to the wild-type or Nf2seeKO mice. To understand if the change in 
density was caused by a difference in nuclei size, we measured the length of the 
longitudinal myometrial nuclei and did not observe a substantial difference 
(Figure 5t).  
 
3.22 Apicobasal polarity and junction condensation is lost in Merlin-
deficient tissue 
Since there was an obvious change in histology in the Nf2eeKO and 
Nf2seeKO mice, we wanted to examine whether cell polarity and cell:cell 
adhesion were altered. We first verified that Merlin was disrupted in our mutant 
endometrium (Figure 6a). Endometrial tissue was isolated from wild-type or Nf2-
deficient mice and analyzed by PCR to determine if Cre mediated recombination 
had occurred.  Using three separate PCR primer sets we established whether the 
uterine tissue was heterozygous or homozygous for the Nf2 targeted allele. In 
addition, we verified the presence of Cre and deletion of Exon 2 following Cre-
mediated recombination. We found that Exon 2 had been recombined in tissue 
expressing Cre indicating deletion of Merlin (Figure 6a). Since Merlin has 
previously been shown to disrupt apicobasal polarity, specifically the Par 
complex, we examined the localization of Par3 in Merlin null endometrial 
tissue(122). While Par3 localizes to the apical surface of the luminal and  
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Figure 6 Merlin loss causes disruption of apicobasal polarity without altering 
apical junctions.  
Merlin loss was examined by PCR for recombination of the targeted Nf2 allele (a). Par3 
staining in wild-type luminal epithelium (b) and glandular epithelium (c) show apical 
localization in wild-type, however Nf2eeKO luminal epithelium (d) has diffuse staining. 
ZO-1 staining in wild-type (e, e’) and Nf2eeKO (f, f’) show minimal changes to the apical 
localization. b-catenin staining in wild-type glands (g, g’), wild-type luminal epithelium (h, 
h’), and Nf2eeKO luminal epithelium (i, i’) show no changes. Yellow dotted line signifies 
the epithelial tissue. Staining of E-cadherin and P-cadherin in wild-type (j, l) and 
Nf2eeKO (k, m) mice at P7 (j-k) and P21 (l-m) show an increased luminal staining of P-
cadherin and minimal changes to E-cadherin at P21. Line intensity graphs of co-
localization of wild-type and Nf2eeKO (n-o) show an increase of P-cadherin at the apical 
lumen at both P7 (n) and P21 (o). 
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glandular epithelium in wild-type mice (Figure 6b-c), there is loss of Par3 at the 
apical surface in the Nf2-deficient luminal epithelium (Figure 6d). This suggests 
apicobasal polarity is disrupted similar to what has been observed in other 
epithelial tissues(122).  
Additionally, since Merlin is critical in junctional maturation, we were 
interested in whether apical junction proteins like ZO-1, b-catenin, and E-
cadherin were mislocalized. ZO-1 was examined by immunofluorescence and 
found to still localize to the apical junctions (Figure 6e-f).  
This was surprising since in other Merlin-deficient epithelial tissues ZO-1 
localizes to the cytoplasm(122). Proper localization of ZO-1 can  
indicate that tight junctions are able to form, however, it does not address 
whether the junctions are fully functional. Additionally, b-catenin, an adherens 
junction protein, was examined for proper localization to the apical junctions. 
Nf2eeKO mice had similar localization of b-catenin to the luminal epithelial 
membrane as wild-type littermates on the endometrial luminal and glandular 
epithelium (Figure 6g-i). E-cadherin was also examined in Nf2eeKO mice 
compared to wild-type mice. E-cadherin appeared relatively similar between wild-
type and mutant mice (Figure 6j’-m’). There was some intense punctate E-
Cadherin staining noted in a subset of the Nf2eeKO mice, not observed in wild-
type littermates (not shown). Thus, the majority of proteins in adherens junctions 
appear to localize properly. 
Interestingly, P-cadherin is another cadherin that is known to be 
expressed within the endometrium(267–269). P-cadherin is involved in mammary 
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tubulogenesis where it is expressed on the cap cells in terminal end buds(270). 
Bazelliéres et al. showed that P-cadherin and E-cadherin can play different roles 
in mechanical stress and cellular tension(271). E-cadherin has been shown to 
strengthen the cell adhesions, while P-cadherin regulates the intercellular 
tension(271). Thus, we decided to examine P-cadherin in the pre-cycling uterus. 
In wild-type uteri, P-cadherin is dispersed throughout the membrane of the 
epithelium, while in the Nf2eeKO mice, P-cadherin localizes to the apical lumen 
(Figure 6j”-m”). This P-cadherin apical localization occurs early during gland 
development at P7 (Figure 1d, Figure 6j”-k”) and intensifies over time observable 
at P21 (Figure 6l”-m”).  
 
3.23 Proliferation decreases and tension increases in Merlin-deficient 
tissue 
In order to determine why the correct endometrial gland architecture did 
not form, endometrial tissue was examined at an earlier stage of gland formation 
e.g. P7 (Figure 1d). Gland formation has been examined in a multitude of 
tissues, however the exact mechanism by which the endometrium forms glands 
is not completely understood. In order for the buds to form and then go through 
tubulogenesis, any combination of proliferation and apoptosis may cause the 
cellular changes necessary for gland formation. Additionally, since changes in P-
cadherin were observed (Figure 6j”-m”), local changes in cell:cell and cell:matrix 
tension likely play a role in the elongation of the gland structure. Proliferation was 
examined following a 2-hour pulse of BrdU. In Nf2eeKO mice, there was a 
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decrease in BrdU incorporation in both the epithelium and the stroma (Figure 7a-
b). The epithelium and the stroma showed about a 5% decrease in BrdU 
incorporation (Figure 7e-f). This suggests there is a small decrease in cellular 
proliferation in the endometrium due to Merlin loss in the epithelium. In addition 
to proliferation, we examined apoptosis using the apoptotic marker cleaved 
caspase 3 (CC3). CC3 levels were low in both wild-type and Nf2eeKO mice and 
no significant difference was observed (Figure 7c-d, g).  
Besides examining proliferation and apoptosis, we were interested in how 
tension was affected in the Nf2eeKO endometrium since P-cadherin localization 
changed. Co-localization of Vinculin and Myosin IIB (myoIIB) indicates an 
increase in cellular tension. When epithelium have low amounts of tension at 
cell:cell contacts in particular at the adherens junctions, this causes a-catenin to 
form a tertiary structure decreasing the association of actin, myoIIB, and Vinculin 
to the adherens junction(272). When a-catenin is under tension then myoIIB and 
Vinculin are able to associate with the junctional complex(272). In addition, 
Vinculin is stabilized at Focal Adhesions (FAs) on the basal membrane as actin-
myosin related tensionincreases(273, 274). Thus, co-localization of Vinculin and 
myoIIB can indicate cell:cell and cell:ECM contacts are under tension. 
Examination of wild-type endometrium shows little to no co-localization of 
Vinculin and myoIIB except in small sections at the basal membrane of the 
luminal epithelium (Figure 8a). The Nf2eeKO mice however, had co-localization 
of Vinculin and myoIIB across a majority of the basal membrane of the luminal 
epithelium (Figure 8b). The co-localization was more intense in Nf2eeKO  
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Figure 7 Proliferation and Apoptosis within the developing endometrium.  
BrdU staining, signifying the amount of proliferation in wild-type (a, a’) and 
Nf2eeKO (b, b’) endometrial epithelium and stroma. Cleaved Caspase 3 (CC3) 
showing the amount of apoptosis in the wild-type (c, c’) and Nf2eeKO (d, d’) 
endometrial epithelium. Quantification of the amount of BrdU positive cells within 
the luminal epithelium (e) and endometrial stroma (f). Percent of cells that have 
CC3 in the luminal epithelium of wild-type versus Nf2eeKO mice (g). * P<0.05 
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endometrium compared to any co-localization observed in the wild-type 
endometrium (Figure 8a-b, e). In addition, pMLC (phospho-Myosin Light Chain) 
is known to indicate areas of high cellular tension. ROCK (Rho-associated 
protein kinase) phosphorylates MLC which causes myosin ATPase to activate 
actin(275).  We observed an increase in the intensity of pMLC at the basal 
membrane in Nf2eeKO mice compared to wild-type mice (Figure 8c-d). A 
comparison of line plots showed a large increase of pMLC on the basal 
membrane of Nf2eeKO endometrium compared to wild-type endometrium 
(Figure 8f). 
To examine tissue tension in a morphological manner, we utilized the 
cellFIT program that generates mathematical equations and common 
assumptions to map differing areas of tension within a cell sheet(276). 
Unfortunately, cellFIT was not able to obtain true cell measurements in uterine 
tissue sections resulting in inconsistent readouts even on the same image. While 
we continued to examine other mathematical modeling systems, we found a 
majority of systems are not designed for in vivo tissue, but rather cell 
culture(277). Cell culture based modeling systems have found that utilizing the 
angle of cell:cell and cell:ECM interactions can help determine where high vs. 
low tension is located (Figure 8h)(277). Using this strategy, we measured the 
cell:cell and cell:ECM angles, in wild-type samples (n=3) and determined the 
wild-type cell:cell: angles are obtuse, while a majority of the mutant (n=3) cell:cell 
angles are acute suggesting that the mutant cells are compressing their apical 
surface (Figure 8g). In addition, the cell:ECM interactions showed   
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Figure 8 Increases in tension at the basal membrane corresponds to an 
increase in F-actin at the apical membrane in Nf2eeKO mice.  
Wild-type (a) and Nf2eeKO (b) endometrium show differing co-localizations of 
Myosin IIB (a’-b’) and Vinculin (a”-b”). pMLC is increased at the basal 
membrane of Nf2eeKO (d, d’) versus wild-type (c, c’) luminal epithelium. 
Comparison of the intensity of Myosin IIB and Vinculin in wild-type and Nf2eeKO 
uteri (e). Quantification of pMLC intensity in wild-type versus Nf2eeKO uteri (f). 
Quantification of the angles observed between the extracellular matrix and the 
basal membrane (Cell:ECM) or apical junctions (Cell:Cell) of the luminal 
epithelium in wild-type (g-h, Cell:ECM median=88°, Cell:Cell median=98°) and 
Nf2eeKO (h-I, Cell:ECM median=96°, Cell:Cell median=81°) mice. Phalloidin 
staining of F-actin in wild-type (j, j’) and Nf2eeKO (k, k’) endometriums (j-k). 
Comparison of the line intensity of Phalloidin at the apical surface of wild-type 
and Nf2eeKO mice from (j-k) images (l). White lines denote where line intensity 
was measured (j’, k’). 
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obtuse angles in the mutant mice compared to acute angles in the wild-type mice 
(Figure 8g, i).  
In order for this switch of cell interaction angles to occur, we hypothesized 
that mutant endometrium is under increased tension.  Additionally, because of 
the direction of the angle changes, we postulated that this could be from 
increased apical constriction producing a contractile actin ring on the apical 
surface of the mutant endometrial epithelium. To examine whether an actin ring 
was present, we stained endometrial tissue with Phalloidin, an F-actin dye, and 
found that Nf2eeKO tissue has more intense Phalloidin staining around the apical 
lumen than the wild-type endometrium (Figure 8j-l). This indicates the potential 
changes in tension observed at the basal membrane may be from apical 
constriction pulling the cells in a manner where they are unable to form a 
glandular structure. 
 
3.24 Wnt signaling is downregulated in Merlin mutants   
 In order to understand what signaling pathways may be involved in the 
lack of adenogenesis, we examined pathways known to be regulated by Merlin 
including the Hippo and b-catenin signaling pathways. Merlin is well known for 
the tissue specific role it can play as a positive regulator of Hippo signaling in 
Drosophila and in mammalian brain and liver(223, 278). Hippo signaling is 
inactive when YAP (Yes-associated protein) or Taz (transcriptional co-activator 
with PDZ-binding motif) translocates into the nucleus and interacts with 
transcription factors like TEAD (TEA domain-containing transcription factor 
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family) proteins to increase target gene expression (Figure 2d). A kinase complex 
made up of MST1/2 (Mammalian Ste20 Kinases 1/2), Sav (Salvador), MOBKL 
A/B (Mps One Binder Kinase activator-like A/B), and Lats1/2 (Large Tumor 
Suppressor 1/2) phosphorylate YAP sequestering it to the cytoplasm where it is 
degraded(54). Wild-type and Nf2eeKO mice at either P7 or P21 showed no 
nuclear Yap staining, suggesting that Hippo signaling is not increased in the 
Merlin-knockout uterus (Figure 9b-e). We confirmed the staining with embryonic 
osteoblasts in cartilage primordium where nuclear YAP staining has been 
previously shown (Figure 9a)(279). To confirm these results, we examined YAP 
downstream targets BIRC3 (Baculoviral IAP repeat containing 3) and CTGF 
(Connective tissue growth factor) by qRT-PCR in uteri isolated from Nf2eeKO 
female mice at P7. While CTGF did not show a significant change between wild-
type and Nf2eeKO mice (Figure 9f), BIRC3 did show an increase in expression 
suggesting some targets of YAP may be increased (Figure 9f). 
 Numerous observations indicate that Wnt signaling is involved in 
endometrial gland development so we also examined Wnt signaling regulators 
and downstream targets (Figure 9g-l). We noticed a slight increase in Axin1 and 
Axin2 (Figure 9g). In addition, we observed an increase in Ccnd1 expression, 
though Ccnd1 is downstream of multiple pathways that may be affected in 
Nf2eeKO mice (Figure 9l). Furthermore, Wnt7a expression increased in the 
Nf2eeKO uterus at P7, but Wnt7a has been implicated as a ligand utilized in the 
planar cell polarity pathway, potentially indicating planar cell polarity is being 
affected in the Nf2eeKO mice (Figure 9k). Myc, a common Wnt downstream   
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Figure 9 Hippo and Wnt signaling in Nf2eeKO Mice.  
Yap staining in embryonic osteoblasts in cartilage primordium as a positive 
control (a, a’). Yap staining in wild-type (b, b’, d, d’) and Nf2eeKO (c, c’, e, e’) 
endometrium. qRT-PCR of Hippo signaling downstream targets CTGF and 
BIRC3 in wild-type and Nf2eeKO mice (f). Axin1 and Axin2 mRNA expression in 
wild-type and Nf2eeKO mice (g). qRT-PCR of Myc (h), Sox9 (i), Sox17 (j), 
Wnt7a (k), and Cyclin D1 (l) in wild-type and Nf2eeKO mice. *P<0.05, **P<0.01, 
***P<0.005 
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target was significantly decreased in Merlin-deficient endometrium (Figure 9h). 
Additionally, another Wnt downstream target, Sox9 was slightly decreased 
(Figure 9i). Sox17 is known in mouse models of gastric cancer to be involved in a 
feedback loop with Wnt signaling. When Wnt signaling increasing, it results in an 
increase in Sox17 that suppresses additional Wnt signals(280). Sox17 
expression was shown to increase in Nf2eeKO mice (Figure 9j)(25, 281). This 
indicates that during initiation of endometrial gland formation, Wnt signaling is 
decreased in Merlin-deficient endometrium. 
  
3.3 Summary 
Previous reports show that Nf2 heterozygous mice have decreased 
fertility, however whether this is due to alterations of the uterus are not 
known(282). We generated a conditional knockout of Merlin in the uterus utilizing 
the Nf2lox/lox mouse crossed to either the Wnt7a-Cre or PR-Cre mouse to create 
endometrial epithelial specific mutants (Nf2eeKO) and whole endometrium 
knockouts (Nf2seeKO) respectively. Both mutants exhibited an aglandular 
phenotype and Nf2seeKO mice were infertile. Given previous work 
demonstrating endometrial glands are essential for proper fertility, the infertility in 
mice lacking Merlin in the uterus could be attributed to decreased or absent 
gland function. We examined endometrial gland specific transcription factors and 
Muc1 expression in Nf2eeKO and Nf2seeKO mice. While a majority of the 
luminal epithelium in Nf2eeKO and Nf2seeKO mice showed similar intensity of 
Sox9, FoxA2, and Muc1 as the wild-type luminal epithelium, there were distinct 
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regions that showed increased intensity. Interestingly, the discrete areas of 
increased Sox9, FoxA2, or Muc1 had similar levels as wild-type glandular 
epithelium. This suggests that Nf2eeKO and Nf2seeKO luminal epithelium can 
differentiate in to glandular epithelium correctly but cannot form the proper 
architecture.  
In order to understand why the glandular architecture may not form 
properly, we examined proliferation, apoptosis, and cellular tension within the 
tissue. We found there were slight decreases in proliferation in Nf2eeKO mice 
compared to wild-type mice. Additionally, we determined that cellular tension was 
increased at the basal membrane of the luminal epithelium in Nf2eeKO mice 
compared to wild-type mice. We found an increase of F-actin at the apical 
surface of Nf2eeKO luminal epithelium compared to wild-type mice suggesting 
an increase in apical constriction. The apical constriction may be pulling on the 
basal membrane causing the increase in tension at the cell:ECM interface.  
 Merlin regulates Hippo signaling, cell adhesion, and cell polarity. When 
examined by immunofluorescence, only apicobasal polarity was significantly 
affected. However, what signaling pathways may be involved in Nf2eeKO and 
Nf2seeKO endometrial gland formation were not clear. We found that other Wnt 
signaling mutant mice have a similar phenotype and a canonical Wnt signaling 
downstream target was decreased as measured by qRT-PCR. Interestingly, we 
also examined a Wnt signaling negative regulator, Sox17, measured by qRT-
PCR and found Sox17 was increased in the Nf2-deficient mice at P7. Alterations 
in tension and cadherins can modulate the levels of Sox17(283) and the nuclear 
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localization of b-catenin(284). This indicates that the observed increase in apical 
P-cadherin may be causing the decrease in Sox17 expression. Another 
hypothesis is that the changes in tension in the Nf2eeKO mice cause the 
decrease in Wnt signaling. This study helps understand the role of polarity, 
tension, and Merlin within endometrial gland development and female infertility. 
Since there are 3.53 million women who are unable to become pregnant in the 
United States, these mouse models will be helpful in understanding female 
infertility and potential treatments (259).    
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Chapter 4: The Role of Merlin in Endometrial Homeostasis 
 
4.1 Introduction 
Merlin is necessary for proper development of the endometrium (Chapter 3). 
Merlin has been shown in other epithelial organs to cause both developmental 
diseases and carcinomas(224, 225). An example is the role Merlin plays in 
epidermal barrier development, where it regulates establishment of adherens 
junctions and apicobasal polarity(122). Merlin-deficient skin no longer forms an 
organized stratified squamous epithelium but rather a disorganized epithelial 
tissue that loses organ function(122).  
Similar to the skin, the uterus is a complex organ that is shed and remodeled 
frequently through menstruation or estrous. The uterus has a multitude of 
functions focused around reproduction, including generating a suitable 
environment for an embryo. The intricacy of the uterus can lead to a variety of 
FRT diseases that are still not completely understood including endometriosis, 
uterine fibroids, and endometrial cancer. Menstruation and estrous cause a re-
organization of the uterus with each cycle; during this process, both cell adhesion 
and cell polarity are re-established. Since Merlin connects cell adhesion and 
apicobasal polarity together(122), Merlin may be necessary for proper 
homeostasis in the uterus as well. Within this dissertation, homeostasis is 
defined as the proper maintenance of the mouse or human endometrium and 
myometrium architecture. Using TCGA (the Cancer Genome Atlas) data we 
found Merlin is mutated, deleted, or amplified in 5% of human endometrial 
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cancers(164, 165). Merlin has also been shown to be regulated post-
translationally when homeostasis is disrupted in the breast as well(285). This 
implies that Merlin may be affected in more cases of endometrial cancer as well.  
Merlin (gene name: NF2) was originally found in Neurofibramotosis type 2, a 
central nervous system tumor disorder, where there was a loss of heterozygosity 
of Merlin. Interestingly, Merlin has been found to cause carcinomas through a 
multitude of pathways including EGFR and Wnt signaling(286, 287). How Merlin 
affects the uterus is not yet well understood, our current knowledge includes the 
fact that Nf2+/- mice are subfertile(219) and from Chapter 3 that conditional Merlin 
knockout causes a loss of endometrial glands and infertility. Understanding how 
Merlin is involved in homeostasis of the adult mouse uterus may help us learn 
more about other endometrial diseases like cancer.  
 
4.2 Results 
4.21 Endometrial epithelium becomes a squamous, stratified epithelium in 
Merlin mutant mice 
After puberty, the endometrium forms an intricate architecture where 
tubules branch off the main lumen and secondary branches form glandular 
epithelium (Figure 1d)(20). Nf2eeKO (Nf2lox/lox; Wnt7a-Cre) and Nf2seeKO 
(Nf2lox/lox; PR-Cre) mice do not form glands by P21 (Chapter 3) but how Merlin 
deficiency affected the post-puberty endometrium is still not understood. Since 
Nf2eeKO mice do not frequently survive past 2 months (Figure 10a), we utilized 
the Nf2seeKO mice to examine how Merlin-deficiency affects endometrial   
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Figure 10 Nf2seeKO mice uteri change after puberty to resemble a 
decidualized uterus.  
Survival curve of Nf2eeKO mice until 100 days when 100% of mice were lost (a). 
Wild-type (b) and Nf2seeKO (c) mice at P21 show a loss of glands in Nf2seeKO 
but no other visible phenotype. By 3 months of age, virgin Nf2seeKO exhibit an 
abnormal morphology with a dense myometrium and stroma compared to wild-
type mice (d-e). Gross morphology of the uteri shows a thick uterine horn in the 
Nf2seeKO mice by 5 months compared to wild-type (f-g), however at 2 months 
the horns look relatively normal (h). Wild-type (i) and Nf2seeKO (j) uteri and 3.5 
days post coitus (DPC) look similar to Nf2seeKO uteri at 3 months (e). 
Interestingly, Nf2seeKO uteri that have been serially mated have an exacerbated 
morphology compared to Nf2seeKo at 3.5 DPC with a thick longitudinal 
myometrium and thin radial myometrium (k).Quantification of the thickness of the 
longitudinal myometrium in µm (l). Quantification of the thickness of the radial 
myometrium in µm (l). *p<0.0033. 
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homeostasis. It should be noted that the reason for death is not known, however, 
it does not appear to be related to the endometrial phenotype. At P21, wild-type 
mice have 8-10 endometrial glands on average within the endometrium (Figure 
4a, f-g, Figure 10b), while Nf2seeKO mice do not form endometrial glands 
(Figure 4g, Figure 10c). Interestingly, by 3 months of age the Nf2seeKO uteri 
significantly changed showing a simpler luminal epithelium with a small ovular 
lumen compared to wild-type endometrium (Figure 10d-e). Additionally, we saw a 
denser stroma and a thicker myometrium than wild-type uteri (Figure 10d-e). The 
gross morphology of mutant uteri show thickened and firm horns compared to 
wild-type uteri at 5 months of age (Figure 10f-g). Around P60, we began to notice 
a vagina with a dark brown coloring in the Nf2seeKO FRT that we continued to 
observe in the older Nf2seeKO females (Figure 10g-h). Interestingly, the 
Nf2seeKO mouse endometrial luminal epithelium is positive for keratin 14 (K14), 
a squamous epithelial marker normally contained in the vaginal epithelium. Wild-
type endometrial luminal epithelium is not positive for K14, therefore this may 
indicate a possible cell fate change in the epithelium. 
The aberrant histology of the Nf2seeKO aged uterus appeared similar to 
an early pregnant uterus (3.5-5.5 days post coitus)(288). We became interested 
in whether this histological phenotype usually observed during normal pregnancy 
could be exacerbated following breeding. Wild-type female uteri at 3.5 DPC 
(days post coitus) had a condensed endometrial stroma that looked similar to 
decidua, the endometrial glands had decreased in size, and the endometrial 
lumen was condensing into a smaller luminal structure (Figure 10i). Nf2seeKO 
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female uteri at 3.5 DPC had a similar condensed endometrial stroma, especially 
around the myometrium with a shrunken endometrial lumen in a circular shape 
(Figure 10j). In addition, we observed serially mated Nf2seeKO females had an 
exacerbated phenotype compared to post-puberty mutant or 3.5 DPC uteri 
(Figure 10e, j, k). In fact, the radial myometrium was significantly thicker in the 
serially mated Nf2seeKO females compared to the wild-type 3.5 DPC. However, 
the longitudinal myometrium was not significantly different (Figure 10l-m). Since 
pregnancy and puberty cause a change in hormonal cycling/changes in the 
hypothalamic-pituitary-gonadal axis, we postulate that hormones may play a role 
in this uterine phenotype.  
 
4.22 Changes in endometrial epithelium coincide with changes in Wnt 
signaling 
In P7 mice, we observed a decrease in proliferation and no increase in 
apoptosis (Figure 7). Therefore, we were interested to know what caused the 
observed increase in cell density after puberty. Initially, we examined Hippo 
signaling since Merlin is a negative regulator of Hippo, and Hippo signaling is 
known to regulate organ size. We noted increases in both BIRC3 and CTGF in 
Nf2seeKO mice at P60 (Figure 11a). Nf2eeKO mice after puberty also showed 
an increase in CTGF but a decrease in BIRC3 (Figure 11e).  In addition, since 
canonical Wnt signaling mutants have previously been shown to affect 
endometrial gland formation and to cause K14+ epithelium(46), we examined Wnt 
signaling downstream targets, Cyclin D1 (Ccnd1) and Myc by qRT-PCR  
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Figure 11 Expression of Hippo and Wnt signaling in Nf2eeKO, Nf2seeKO, and 
Merlin-deficient primary cells.  
Expression of the Hippo signaling downstream targets, BIRC3 and CTGF, in Nf2seeKO 
(a), Nf2eeKO (e), and Merlin-deficient endometrial cells (Nf2KOcells, i). Expression of 
Myc, a Wnt signaling downstream target, in Nf2seeKO (b), Nf2eeKO (f), and Nf2KOcells 
(j). Quantification of mRNA expression in Ccnd1 in Nf2seeKO (c), Nf2eeKO (g), and 
Nf2KOcells (k). Sox17 mRNA expression in Nf2seeKO (d), Nf2eeKO (h), and 
Nf2KOcells (l). Stable normalized genes were used *P<0.05, **P<0.01, ***P<0.005 
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(Figure 11b-c, f-g). Interestingly, in aged Nf2seeKO and Nf2eeKO mice, we 
observed an increase in both Ccnd1 and Myc (Figure 11b-c, f-g). We also 
examined the Wnt signaling negative regulator, Sox17, which was shown to 
increase in P7 Nf2eeKO mice. In both Nf2eeKO and Nf2seeKO post-puberty 
mice, we found a substantial decrease in Sox17 mRNA expression (Figure 11d, 
h). Furthermore, when endometrial epithelium was isolated and put into culture, 
we observed a similar change in mRNA expression of BIRC3, CTGF, Ccnd1, 
Myc, and Sox17 (Figure 11i-l). This suggests that after puberty there is a switch 
in Merlin null mice from loss of Wnt signaling to overexpression of Wnt signaling 
that may be hormone related. 
 
4.3 Summary 
Merlin is necessary for fertility (Figure 4h-j) in female mice and is also 
necessary for proper homeostasis of uterine tissues. Loss of Merlin causes an 
abrupt change to all compartments within the uterus (myometrium, endometrial 
stroma, and endometrial epithelium). Changes within all the tissues of the uterus 
on an endometrial specific knockout is not necessarily surprising since past work 
has shown that the endometrial epithelium communicates with both the stroma 
and the myometrium(248, 266, 289).  However, since a majority of Nf2eeKO 
mice are not able to survive to 4 months, it is not clear if this is due to the 
epithelium, or a combination of signaling from the stroma and epithelium. 
The endometrial epithelium is fascinating because we observe a cell fate 
change from K14- to K14+ tissue. This implies that loss of Merlin can cause a cell 
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fate change within epithelial cells. In addition, Wnt signaling appears to 
significantly increase in the uterine tissue based on mRNA expression of 
downstream targets. Both the Wnt7a and b-catenin conditional knockout mice 
also show a change in endometrial epithelial architecture, however it is not 
known whether canonical Wnt signaling changes in the older Wnt7a and b-
catenin knockout females(46, 290). The increase observed in Ccnd1 and Myc 
are also observed in primary cells isolated in culture. Since epithelial cells in 
culture proliferate in order to reach confluency, this increase in Ccnd1 and Myc 
are not unexpected and correlates with other data that shows mRNA expression 
is upset quickly when primary endometrial epithelial cells are cultured. Since the 
histological changes occur after puberty and are more pronounced in parous 
females versus nulliparous females, we hypothesize that the changes in uterine 
architecture and potentially the overexpression of Wnt signaling are related to 
hormonal fluctuations. This study shows that Merlin loss affects both 
development and homeostasis of the uterus and more work is necessary to 
understand how Merlin affects the aging uterus.  
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Chapter 5: Loss of polarity alters proliferation and differentiation in low-
grade endometrial cancers by disrupting Notch signaling 
This chapter is based upon Williams, E., Villar-Prados, A., Broaddus, R., 
Gladden, A. (2017) Loss of polarity alters proliferation and differentiation in low-
grade endometrial cancers by disrupting Notch signaling. PLoS ONE 12 (12): 
e0189081. https://doi.org/ 10.1371/journal.pone.0189081 is licensed under CC 
BY (Creative Commons Attribution license) by PLoS One. 
 
5.1 Introduction 
Merlin has been shown to affect endometrial homeostasis and proper 
polarity protein localization in the endometrial epithelium (Chapter 3-4). Polarity 
genes are shown as being mutated, amplified or deleted in 37% of endometrial 
adenocarcinomas in the TCGA database(164, 165). Alterations in members of 
the Par complex accounts for 18% of these cancer cases(164, 165).  These 
members include Par3, aPKC, and Par6. In general, polarity complexes are 
necessary for proper apical and basal membrane formation; this functionally is 
dependent on the integrity/completeness of the complex. Accordingly, 
dysregulation or disruption of any polarity gene or protein members can cause 
mislocalization and dysfunction of all polarity proteins irrespective of mutation, 
gene amplification, deletion, or epigenetic changes(103). Apicobasal polarity, 
specifically the Par complex is known to be affected in a multitude of 
cancers(138, 166, 184, 291). As previously discussed, Par3 loss causes an 
increase in metastasis in some breast cancer mouse models(138).  Conditional 
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Par3 knockout in epidermal tissue causes an increase in melanoma and 
hyperplasia of melanocytes when a skin carcinogen is applied(292).  While Par3 
has been shown to increase tumor formation and affect tumor progression, there 
are few studies to understand how Par3 and the Par complex is involved in the 
formation of tumors.  
The Par complex is known to be necessary for proper 
compartmentalization of membrane receptor signaling. For example, Notch 
signaling requires Par3 for the asymmetric division of Notch in mouse radial glial 
cells(81). In addition, Par complex regulators like Merlin are known to affect the 
proper localization of transmembrane proteins like Notch(80). The correct 
membrane localization of EGFR (epidermal growth factor receptor), a 
transmembrane protein has been shown to be necessary for proper vulval 
development in C. elegans(293). Another set of receptor tyrosine kinases, 
FGFRs (fibroblast growth factor receptors) are known to localize to different 
compartments within the same cell-type, thus localization of each may be  
necessary for coordinating different signaling pathways within cells(294). The 
Frizzled receptors involved in canonical Wnt signaling or planar cell polarity 
localize to different areas of the membrane in the same cell-type(56). This 
suggests that correct compartmentalization of receptors is necessary for proper 
membrane-bound receptor signaling. Interestingly, while it is known that the 
different Notch receptor extracellular domains determine the capability to localize 
to the membrane and efficiency to be cleaved, it is not well understood how 
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specific membrane localization of the receptors plays a role in Notch 
signaling(77).  
As discussed in Chapter 1, the canonical Notch signaling pathway has a 
membrane-bound receptor and ligand that must interact for increased expression 
of downstream targets. Notch signaling is hypothesized to function as a switch 
causing different phenotypes depending on the overall level of NICD (Notch 
intracellular domain). This feature is not dependent on the specific Notch 
receptor being utilized(77, 79). While there is a basic understanding of Notch 
signaling, it’s activity in a multitude of diseases like cancer, highlights the need to 
further understand the Notch pathway.  
Previous work has shown that Notch signaling can be tumor suppressive or 
oncogenic in a cancer dependent manner(295–297). In the cervix, Notch 
signaling appears to be tumor suppressive(72, 298, 299). In contrast, Notch is 
upregulated in ovarian cancer, implying it is oncogenic. The role that Notch plays 
in reproductive cancers is unclear and controversial(300).  Interestingly, two 
different conditional Notch1 activating mutants have been generated in the FRT 
(Rosa26N1ICD/N1ICD; Amhr2-Cre [1], Rosa26N1ICD/N1ICD; PR-Cre [2])(26, 74). The 
Amhr2 mutant drives overexpression of Notch1 in areas of the ovary, endometrial 
stromal cells, and myometrium, while the PR mutant forces overexpression of 
Notch1 in the entire endometrium, ovary, and oviduct(26, 74). The  
Rosa26N1ICD/N1ICD; Amhr2-Cre mouse was found to have defects in the 
architecture of the oviduct and cause cyst formation at around 3-4 months of age.  
Similar to Nf2eeKO and Nf2seeKO mice, Rosa26N1ICD/N1ICD; PR-Cre mice do not 
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form endometrial glands(26, 74). Both mutants were determined to be 
infertile(26, 74). Whether these mice show similar decidual-like abnormalities as 
the Nf2seeKO mice in the post-puberty uterine tissues is not known. It is possible 
that the aglandular phenotype seen in both mice may be related to the disruption 
of apicobasal polarity. Accordingly, we postulate that apicobasal polarity is critical 
for proper endometrial maintenance, whereby its loss and dysregulation of Notch 
signaling is involved in endometrial tumorigenesis.  
 
5.2  Results 
5.21 Loss of polarity, but not E-cadherin localization, in low-grade 
endometrial cancer  
Normal human endometrium consists of a single layer of polarized 
glandular epithelium resting on the basement membrane and surrounded by 
adjacent stromal cells(301). To determine the status of apicobasal polarity in 
endometrial cancer (EC), we first examined the localization of the apical protein, 
Ezrin and the apical polarity protein, Par3 in normal endometrium in relation to 
the localization of adherens junction protein, E-cadherin. Both Par3 and Ezrin 
localized to the apical side of the polarized glandular epithelium of normal 
endometrium (Figure 12a, d). We next examined Ezrin and Par3 localization in 
G1 EC and G2 EC samples. We observed a decreased apical localization of both 
Par3 and Ezrin in glandular structures of the tumors compared to minimal  
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Figure 12 Loss of apicobasal polarity occurs in low-grade endometrial cancer.  
Human endometrial tissue (a, a’, d, d’, d”), normal; (b, b’, e, e’, e”) grade 1 
endometrioid endometrial carcinoma, G1 EEC; and (c, c’, f, f’, f”) grade 2 endometrioid 
endometrial carcinoma, G2 EEC stained with antibodies for the apical proteins (a-c) 
Ezrin or (d-f) Par3, E-cadherin and DAPI. Scale bar, 20 μm. Asterisks indicate glandular 
lumen and arrows show apical localizing protein (a’) Ezrin or (d’) Par3. Scale bar, 20 
μm. (g and h) Quantification of (a-c) Ezrin or (d-f) Par3 apical localization in 10 lumens 
of each sample (n = 3 normal, n = 2 G1 EEC, n = 2 G2 EEC) showing loss of apical 
protein localization in low-grade EEC. Error bars represent SEM.  
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changes in E-cadherin localization (Figure 12a- f, Figure 13a-c, e).  
Quantification of the percentage of glandular epithelial cells with apical 
localization of either Ezrin or Par3 shows nearly a four-fold decrease in ECs 
compared to normal endometrium (Figure 12g-h). Additionally, the presence of 
the apically localized differentiation marker acetylated tubulin, which marks 
cilia(302–304), was decreased in G1 and G2 EC (Figure 13f-i). These data 
indicate that apicobasal polarity is disrupted in low-grade endometrial tumors.  
We previously demonstrated that establishment of apicobasal polarity in 
developing epithelial tissue requires adherens junction (AJ) formation(122). Loss 
of polarity is closely associated with advanced or metastatic tumors and 
epithelial-to-mesenchymal transition (EMT), a transcriptional program that 
downregulates the AJ protein, E-cadherin (305). To investigate E-cadherin 
protein expression and localization in G1 and G2 ECs lacking apicobasal polarity, 
we stained normal endometrium and ECs for E-cadherin. Interestingly, although 
apicobasal polarity was disrupted, E-cadherin remained present and localized to 
the basolateral membranes of glandular epithelial cells in G1 and G2 EC (Figure 
13a-c, e).  Subsequently in more advanced G3 EC, we see loss of E-cadherin 
expression indicating loss of E-cadherin is a late event in EC (Figure 13d). 
Overall, these data demonstrate that loss of apicobasal polarity, but not the AJ 
marker E-cadherin, corresponds with decreased cellular differentiation in low-
grade endometrial tumors. 
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Figure 13 E-cadherin localization and cilia presence in endometrial cancer with 
disrupted polarity.  
Normal endometrium (a, a’), G1 EEC (b, b’) and G2 EEC (c, c’) stained with an antibody 
against E-cadherin and DAPI. Images of (a-c) E-cadherin staining showing localization 
to the apical junctions and lateral border in normal endometrium, G1 EEC, and G2 EEC 
(a’-c’). Asterisks indicate glandular lumen. G3 EEC stained with antibodies against E-
cadherin (green) with DAPI (d) or with E-cadherin staining only (d’) showing loss of 
localization to the apical junctions and lateral borders. Ratio of the apical localization of 
Par3 to the basolateral localization of E-cadherin (e). Localization of Par3 or E-cadherin 
was determined from 10 lumens of each sample (n = 3 normal, n = 4 EEC). Staining with 
antibodies against acetylated tubulin (Ac. Tub), a maker of cilia, pan cytokeratin (Pan 
Cyto.), an epithelial maker, and DAPI in normal endometrium (f), G1 EEC (g), and G2 
EEC (h) shows a decrease in cilia indicative of decreased differentiation. Quantification 
of the number of cilia found per gland determined from 10 lumens of each sample (i, n=3 
normal, n=5 EEC). Error bars represent SEM. * <0.05. Scale bar, 20 μm 
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5.22 Disruption of polarity in a 3D cell model phenocopies changes in 
cellular differentiation observed in low-grade endometrial tumors.  
To understand how apicobasal polarity was regulating differentiation we 
utilized a commonly used polarized epithelial cell model, Madin-Darby Canine  
Kidney (MDCK) cells, as we were unable to obtain normal endometrial epithelial 
cells. Apicobasal polarity was disrupted through shRNA-mediated knockdown of 
Par3, Ezrin or Merlin (Figure 14a-c). To better recapitulate the 3D organization of 
the endometrium, we cultured Scramble-shRNA (Scr-shRNA), Par3-shRNA 
(Par3 kd) and Ezrin-shRNA (Ezrin kd) cells in a 3D matrix and stained the cells 
for acetylated tubulin, a marker of cilia and Phalloidin or E-cadherin and ZO-1 
(Figure 14d-f, k-m). Scr-shRNA cells formed single lumen structures with 
numerous cells extending cilia into the luminal space (Figure 14d, g-h).  
Confirming previous studies, we observed Par3 kd, Ezrin kd, and Merlin-shRNA 
(Nf2 kd) cells formed multi-lumen structures(134, 306) similar to what was 
observed in human ECs (Figure 14e-h, not shown)(307). Additionally, we 
observed an overall decrease in the presence of cilia in Par3 kd and Ezrin kd 
analogous to our observations in endometrial cancer (Figure 14h).  Both the 
multi-lumen phenotype and the loss of cilia are indicative of a less differentiated 
state in epithelial cells (302–304, 307–309), implying that disruption of apicobasal 
polarity in the cell-based model caused a less differentiated state similar to ECs. 
To provide additional evidence for altered differentiation in our Par3 kd 
and Ezrin kd cell model, we examined the localization of the polarized tight 
junction (TJ) marker ZO-1 and the formation of functional TJs, a known sign of  
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Figure 14 Depletion of apical polarity proteins cause an increase in multiple lumen 
structures and a decrease in differentiation markers in epithelial 3D cell culture.  
Western blot analysis of (a) Par3, (b) Ezrin, and (c) Merlin knockdown in the MDCK cells 
compared to a scramble control (a-c). Immunofluorescence staining on (d) Scramble-
shRNA (Scr-shRNA), (e) Par3-shRNA (Par3 kd), and (f) Ezrin-shRNA (Ezrin kd) 3D 
cysts for primary cilia by acetylated tubulin (ac. tub) and actin by Phalloidin (d-f). Scale 
bar, 20 μm. Quantification of the (g) number of lumens (n = 2) and (h) cilia (n = 1) 
present within all 3D cysts compared to scramble control cells. Par3 kd, Ezrin kd, and 
Scr-shRNA had at least 49 cysts, 13 cysts, or 70 cysts examined per independent 
experiment (g, h). Abnormal cilia include cysts without cilia present or cilia that appears 
abnormal (h). Error bars represent SEM. Transepithelial resistance demonstrates loss of 
functional TJ in Par3 kd and Ezrin kd cells compared to Scr-shRNA cells calculated by 
Ohms per cm2 (i). Quantification of the number of BrdU positive cells in Scr-shRNA, 
Par3 kd, and Ezrin kd cells (j). Orthogonal view of (k) scr-shRNA, (l) Ezrin kd, or (m) 
Par3 kd with E-cadherin (green), ZO-1 (red), and DAPI showing multiple lumens in cysts 
depleted of apical polarity proteins (k-m). Immunofluorescence staining for ZO-1 shows 
altered TJ protein localization in Par3 kd and Ezrin kd cells indicative of decrease in 
differentiation by loss of epithelial cell junctions (n-p). E-cadherin is also stained to label 
junctional complexes. Scale bar, 20 μm. ZO-1 only staining to show the aggregation of 
ZO-1 at tricellular junctions in white (n’-p’). Line plots of (n-p) showing intensity of E-
cadherin (green line) and ZO-1 (red line) on the yellow line in the respective image, Scr-
shRNA (q), Par3 kd (r), and Ezrin kd (s). Note the overlap in E-cadherin and ZO-1 
intensities in Scr-shRNA compared to distinct peaks of ZO-1 intensity in Par3 kd and 
Ezrin kd indicative of mislocalized ZO-1 (q-s). Increased BrdU incorporation observed in 
Par3 kd and Ezrin kd cell lines compared to the Scr-shRNA cells (j, t-v). BrdU only 
staining (t’-v’). Scale bar, 20 μm. *P<0.05 
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differentiation in MDCK cells(303).  The Par3 kd and Ezrin kd cells displayed high 
concentrations of ZO-1 at tricellular contacts; however, ZO-1 levels were low or 
absent at other apical contact points (Figure 14n-p). Similarly, in 3D cultures ZO-
1 had a disorganized staining pattern in the Par3 kd and Ezrin kd cells compared 
to control cells where it localized to the apical junctional border (Figure 14k-m).  
Additionally, the Scr-shRNA cells show an increase in TER over time; by 
contrast, the Par3 kd, as previously described (256), and Ezrin kd cell lines do 
not increase TER to the same degree, that these cells are less differentiated and 
cannot form a functional polarized TJ (Figure 14i). We also sought to determine 
whether disruption of apicobasal polarity increased cell proliferation, another 
marker of decreased cell differentiation. Cells depleted of either Par3 or Ezrin 
displayed increased BrdU incorporation compared to the control cells (Figure 14j, 
t-v). In concordance with our observations in low-grade endometrial cancer, 
these data demonstrate that disruption of apicobasal polarity decreases 
differentiation and increases proliferation of epithelial cells.  
 
5.23 Disruption of apicobasal polarity decreases Notch signaling in 
epithelial cells and in low-grade endometrial cancer.  
To examine the underlying signaling pathways that could regulate differentiation 
in cells with disrupted polarity we utilized our Scr-shRNA, Par3 kd, Ezrin kd, and 
Nf2 kd cells.  We examined Notch signaling as it regulates proliferation and 
differentiation in a tissue-specific manner and in the normal endometrium(245, 
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310–313). Notch signaling is tightly regulated during the menstrual cycle to assist 
in increasing and decreasing proliferation and differentiation(245). Furthermore, 
in Drosophila, Notch receptor localization is affected by Merlin which is known to 
regulate polarity(80). Using qRT-PCR we found MDCK cells express Notch1 and 
Notch2, and the Notch ligands, Jag1 and Jag2, along with several Notch targets 
known to play a role in differentiation and proliferation including HEYL, HEY1, 
and p21 (Figure 15a-c)(310–313). We observed a significant decrease in the 
expression of Notch receptors, Notch ligands, and Notch downstream targets in 
Par3 kd, Ezrin kd, and Nf2 kd cells indicating that altered apicobasal polarity 
disrupts Notch signaling in this mammalian cell-based model (Figure 15d-x). 
We next asked whether a similar change occurs in the Notch signaling 
pathway in low-grade ECs. We performed qRT-PCR with normal endometrium, 
G1, and G2 EC samples. We observed a significant decrease in the Notch 
downstream targets, HEYL and HES1 and the Notch ligand, Jag1, indicating that 
overall Notch signaling is decreased in low-grade EC (Figure 16d-f). Additionally, 
we detected a significant decrease in the transcript levels of the Notch receptor, 
Notch4 but no decrease in Notch1 or Notch2 (Figure 16a-c). Previous work has 
demonstrated that overall levels of active Notch intracellular domain is critical for 
downstream Notch signaling suggesting that Notch1 and/or Notch2 protein could 
be regulated in other manners in low-grade EC(78, 314).  
Our observation that Notch1 and Notch2 mRNA expression levels were 
similar, but that downstream targets were significantly reduced, in EC compared 
to normal samples, prompted us to examine the Notch1 and Notch2 proteins.   
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Figure 15 Notch signaling decreases in Par3, Ezrin, and Merlin depleted epithelial 
cells.  
mRNA expression of Notch receptors (a), Notch ligands (b), and Notch downstream 
targets (c) expressed in wild-type MDCK cells (a-c). qRT-PCR analysis of Notch1 (d-f), 
Notch2 (g-i), JAG1 (j-l), JAG2 (m-o), p21 (p, s, v), HEYL (q, t, w), or HEY1 (r, u, x) 
expression in Scr-shRNA, Par3 kd (d, g, j, m, p-r), Ezrin kd (e, h, k, n, s-v), and Nf2 kd 
(f, i, l, o, v-x) cells. Samples were done in triplicate. Error bars signify SEM. * <0.05, ** 
<0.001, ***<0.0001 
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Figure 16 Notch downstream signaling and receptor localization is disrupted in 
low-grade endometrial cancer.  
qRT-PCR of Notch receptors, ligands, and downstream targets in normal and in low-
grade (G1 & G2 EEC) endometrial cancer (a-f). The Notch receptor, Notch1 (a) and 
Notch2 (b) show no change in expression while Notch4 (c) is decreased. Notch ligand 
Jag1 (d) and downstream targets HEYL (e) and HES1 (f) are down regulated in low-
grade endometrial cancer. Notch1 (a) and Notch2 (b) data was analyzed using ΔCT with 
the Tata box binding protein (DBP) as the reference gene with 7 samples for Normal, G1 
EEC, and G2 EEC. Notch4 (c), Jag1 (d), HES1 (e), and HEYL (f) were analyzed by 
calculating the number of molecules of the gene of interest compared to 18SrRNA (c-f, 
%18SrRNA). Tukey box plots were used with SEM where + is the mean value and • are 
outliers. Normal (n = 10), G1 EEC (n = 9), and G2 EEC (n = 22). Immunofluorescence of 
Notch receptors showing localization of Notch1 (g-i, g’-i’) and Notch2 (j-l, j’-l’) in normal 
endometrium (g, j), G1 EEC (h, k), and G2 EEC (i, l). E-cadherin marks the basolateral 
cell:cell contacts (g-l). Asterisks signify the lumen. Scale bar, 20 μm. Images of (g-l) with 
Notch1 or Notch2 respectively showing localization to the lumen (g’-l’). Arrows denote 
lateral localization of Notch1 or Notch2. 
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The Notch receptors are membrane-bound proteins whose activation may be 
affected by subcellular localization(315). In normal human endometrium Notch1 
and Notch2 localize to the basolateral and lateral membranes of the glandular 
epithelial cells, respectively (Figure 16g, j). In low-grade ECs, by contrast, neither 
Notch1 nor Notch2 receptor proteins localize correctly to the lateral membrane of 
epithelial cells (Figure 16g-l).  Moreover, Notch1 and Notch2 protein levels are 
decreased in the tumor. Collectively, these data show that low-grade ECs have 
disrupted apicobasal polarity and mislocalized and/or reduced protein levels of 
Notch1 and Notch2 receptors that may lead to the overall decrease observed in 
Notch downstream targets.  
 
5.24 Expression of Par3 in endometrial cancer cells promotes 
differentiation and decreased proliferation.  
To determine whether establishment of apicobasal polarity alters 
differentiation or proliferation in endometrial cancer, we assayed endometrial 
cancer cell lines for changes in apical polarity proteins. We examined Par3 
expression in a panel of endometrial cancer cell lines from G1, G2, and G3 
tumors(316). Western blot analysis revealed that Par3 was not readily detected 
in a majority of the endometrial cancer cell lines (Figure 17a). Not surprisingly 
since many of the cancer cell lines are well differentiated, detectable levels of E-
cadherin were observed (Figure 17a). To determine how tumor cells would 
respond to Par3 expression, we overexpressed Par3 in Ishikawa and HEC-1-A 
cells (Figure 17b-c).  
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Figure 17 Expressing Par3 in endometrial cancer cell lines cause differentiation 
phenotypes.  
Western blot analysis of a panel of endometrial cancer cell lines (HEC-1-B, HEC-1-A, 
Ishikawa, ECC-1, HEC-50, MFE-280, and MFE-296) for Par3 and E-cadherin (a). 
Ishikawa and ECC-1 are well-differentiated cell lines, HEC-1-A, HEC-1-B, MFE-296 are 
moderately differentiated cell lines, and HEC-50, MFE-280 are poorly differentiated cell 
lines (a). Western blot analysis of Par3 in control transfection (control) and Myc-Par3 
overexpression in Hec-1-A (b) and Ishikawa (c) cells (b-c). Parental (d, f) or exogenous 
Par3 (e, g) in HEC-1-A (d-e) or Ishikawa (f-g) cells stained with ZO-1 (red), Myc (green), 
and DAPI (d-g). Scale bar, 20 μM. ZO-1 only staining (d’-g’). Z-plane showing ZO-1, 
Myc and/or DAPI staining (d”-g”, d”’-g”’, d””-g””). Quantification of disorganized ZO-1 
in the parental (n = 3) and Par3 overexpression HEC-1-A cells (n = 3) for at least three 
regions of interest (ROI) per experiment (h). Error bars represent. SEM **<0.01. 
Quantification of disorganized ZO-1 in the parental (n = 3) and Par3 overexpression 
Ishikawa cells (n = 3) for at least three regions of interest (ROI) per experiment (i). Error 
bars represent. SEM *<0.05. 
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In contrast to parental cells lacking Par3, in which the TJ protein ZO-1 did 
not localize to apical cell contacts in an organized pattern, we observed a more 
fence-like organization of ZO-1 in cells overexpressing Par3 (Figure 17d-i).  
These data are concordant with our previous observations indicating Par3 loss 
causes decreased differentiation in MDCK cells (Figure 14n-s). In addition, cells 
ectopically expressing Par3 showed lower levels of proliferation than in the 
parental endometrial tumor cell lines lacking Par3, as visualized by BrdU 
incorporation (Figure 18a-f). Finally, cells expressing exogenous Par3 showed an 
increase in Notch1 localization to cell:cell contacts compared to cytoplasmic 
Notch1 localization in parental cells with reduced levels of Par3 (Figure 18g-h). 
Interestingly, HES-1 (a Notch downstream target) also trended toward an 
increase in both Par3 overexpression cell lines (Figure 19a,d). These data 
provide evidence that expression and apical localization of Par3 is critical for the 
proper differentiation of the endometrial epithelium cells, and that disruption of 
apicobasal polarity affects the ability of endometrial epithelium to regulate 
differentiation, proliferation, and Notch receptor localization (Figure 18i).  
 
5.25 Decreases in proliferation and migration observed in Par3 
overexpressing cells is due to Notch signaling.  
 Increased migration is a hallmark of cancer cells in culture, we examined 
migration in the endometrial cancer cell lines in the presence or absence of Par3. 
Par3 overexpression was found to decrease the distance HEC-1-A cells moved 
(Figure 19b, g-j). In addition, a similar trend was observed in Ishikawa cells, 
where Par3 overexpression decreased the distance that cells traveled  
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Figure 18 Expressing Par3 in endometrial cancer cell lines blocks proliferation.  
Staining of parental (a, c) and Par3 overexpressing (b, d) Hec-1-A (a-b) and Ishikawa 
(c-d) cells for Par3, BrdU, and DAPI (a-d). Scale bar, 20 μM. BrdU only staining (a’-d’). 
Quantification of BrdU incorporation in the parental (n = 3) and Par3 overexpression (n = 
3) in HEC-1-A (e) and Ishikawa (f) cells for at least three ROI per experiment. Error bars 
represent. SEM *<0.05. ***<0.001. Parental HEC-1-A (g) or HEC-1-A with exogenous 
Par3 (h) stained with DAPI and Notch1 (g-h). Schematic of proposed model for how 
apicobasal polarity controls differentiation of endometrial epithelial cells by regulating 
Notch receptor localization and, Notch downstream targets that modulate proliferation 
and differentiation (i). 
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(Figure 19e, k-n). To determine if the changes to proliferation and migration were 
related to Notch signaling, we utilized the g-secretase inhibitor DAPT (N-[N-(3,5-
Difluorophenacetyl)-L-alanyl]-S-phenylglycine t-butyl ester). Parental and Par3 
overexpressing HEC-1-A and Ishikawa cells were treated with DAPT. HES-1 
mRNA levels confirmed Notch signaling was inhibited when either parental or 
Par3 overexpression cells were treated (Figure 19a,d). The amount of distance 
traveled was measured and it was determined Par3 expressing cells treated with 
DAPT had similar amounts of migration as either HEC-1-A or Ishikawa parental 
cell lines respectively treated with DAPT (Figure 19b, e, g-n). Additionally, BrdU 
incorporation was shown to be similar between parental cell lines and Par3 
overexpression cell lines when treated with DAPT (Figure 19c, f, o-r). These 
results demonstrate that Par3 expression increases Notch signaling in 
endometrial cancer cell lines resulting in decreased proliferation and migration. 
 
5.26 PTEN loss decreases the effectiveness of Par3 expression in 
endometrial cancer cells 
PTEN (phosphatase and tensin homolog) is mutated in at least 50% of 
low-grade endometrial cancer cases, with 75% of cases showing protein 
loss(196). This indicates inactivation of PTEN can occur through either genomic 
mutation or post-translational mechanisms and deletion of PTEN can cause 
endometrial cancer in vivo(36, 196). PTEN is known as a negative regulator of 
the PI3K (Phosphoinositide 3-kinase) signaling pathway by converting the 
membrane lipid PIP3 (phosphatidylinositol (3,4,5)-triphosphate) to PIP2 
(phosphatidylinositol (3,4,5)-biphosphate as previously discussed in Chapter 1  
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Figure 19 Inhibiting Notch signaling rescues Par3 mediated changes in migration 
and proliferation.  
qRT-PCR analysis of the Notch target HES-1 in parental, Par3 overexpression and 
DAPT treated HEC-1-A (a) and Ishikawa (d) cells (a, d). Quantification of cell migration 
for HEC-1-A (b) and Ishikawa (e) parental, Par3 overexpression, and cells treated with 
the g-secretase inhibitor (DAPT) to block Notch signaling (b, e). Quantification of BrdU 
incorporation in the parental, Par3 overexpression, and DAPT treated HEC-1-A (c) and 
Ishikawa (f) cells (c-f). Images showing the start and end of migration assays performed 
to examine rate of migration for HEC-1-A (g-j, g’-j’) and Ishikawa (k-n, k’-n’) parental 
cells (g, k), Par3 expression cells (h, l), and cells treated with DAPT (i-j, m-n). 
Immunofluorescent analysis of BrdU incorporation in HEC-1-A or Ishikawa parental cells 
treated with DAPT (o, q, o’, q’) or Par3 expressing cells treated with DAPT (p, r, p’, r’). 
Top panels (o-r) show BrdU (green) with DAPI (blue) staining and panels (o’-r’) show 
BrdU staining alone. Scale bar, 20 μM.*P<0.05, ***P<0.0001. 
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(Figure 20a)(317). PIP3 is necessary for proper formation of the basal membrane 
and PIP2 is found at the apical membrane in epithelium (Figure 20a)(193, 318). 
PTEN is also important for proper apical protein localization and is necessary for 
the formation of the apical membrane in epithelial cells(132). In fact, PTEN binds 
Par3 on the third PDZ binding domain (Figure 20b)(127, 131). It has been 
hypothesized that PTEN is able to assist in apicobasal polarity establishment 
through actin organization or apical protein localization(127, 131). 
Since PTEN is inactivated in a majority of low-grade endometrial cancers, 
we examined PTEN protein in the panel of seven endometrial cancer cell lines 
previously examined for Par3 (Figure 17a, Figure 20c). We observed that many 
of the cell lines had low levels of PTEN including Ishikawa cells. In order to 
understand what role PTEN plays, we compared the phenotypes between the 
Ishikawa Par3 expression cell line and two cell lines containing PTEN: HEC-1-A 
and MFE-280 Par3 expression cell lines (Figure 20a). Initial observations showed 
that HEC-1-A cells had a more pronounced decrease in proliferation and the 
MFE-280 cells even showed a change from a multi-layer epithelial sheet to 
monolayer or bilayer epithelial sheet (Figure 18a-d, Figure 20d-e). Notch1 
localization to the membrane increases in both Ishikawa and HEC-1-A cell lines 
when Par3 is expressed, however, it was more evident in the HEC-1-A Par3 
expression cell lines (Figure 16g-h, Figure 20f-g). Ishikawa Par3 expressing cells 
reacted more to DAPT, the Notch signaling inhibitor, then HEC-1-A Par3 
expressing cells in terms of proliferation and changes in HES-1 expression 
(Figure 19a, c-d, f, o-r). 
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Figure 20 The role of tumor suppressor PTEN in Par3-depletion phenotypes.     
PI3K (Phosphoinositide 3-kinase) signaling consists of PTEN converting PIP3 to PIP2 
and PI3K converting PIP2 to PIP3(a)(317). PIP3 causes activation of AKT (protein kinase 
B) which leads to inhibition of apoptosis and increases in cell growth (a). PIP2 localizes 
to the apical membrane while PIP3 is involved in basal membrane formation (a)(193, 
318). Par3 binding partners include Par6, Numb, Kif3a, and PTEN (b). Western blot 
analysis of PTEN in seven endometrial cancer cell lines including HEC-1-B, HEC-1-A, 
Ishikawa, ECC-1, HEC-50, MFE-280, and MFE-296 (c). XZ-plane images of E-cadherin, 
ZO-1, and DAPI in MFE-280 parental (d) and Par3 overexpression (e) cells. Parental 
Ishikawa cells (f) or Ishikawa cells with exogenous Par3 (g) stained with DAPI and 
Notch1 (f-g). Quantification of invasion in ECs categorized by PTEN mutations, polarity 
mutations, or a combination of the two (h). Percentage of ECs by stage that have PTEN 
mutations, polarity mutations or a combination of the two (i). Quantification of the age of 
patients with PTEN mutations, polarity mutations, or a combination of the two (j).  
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Figure 20g)(164, 165). In addition, lower FIGO stage tumors have high amounts 
of polarity and PTEN mutations (Figure 20h)(164, 165). Finally, the age of 
patients diagnosed with endometrial cancer trended toward a decrease with 
polarity mutations with or without PTEN mutations in combination (Figure 
20i)(164, 165). This points toward polarity potentially being involved in the low-
grade or initial stages of endometrial cancer in addition to inactivation of PTEN. 
 
5.3 Summary 
From previous chapters, we found that Merlin regulates apicobasal 
polarity in the endometrium and is necessary for proper endometrial 
homeostasis. Polarity is frequently disrupted in epithelial cancers including 
endometrial cancer. We determined that similar to the Nf2eeKO mice, polarity 
was disrupted in early stage endometrial cancers, while E-cadherin exhibited 
relatively normal staining, demonstrating that cell polarity and cell adhesion can 
be exclusively affected. In order to understand how polarity was affecting the 
underlying biology of endometrial cancer, we utilized both canine kidney (MDCK) 
cells in three-dimensional cultures and endometrial cancer cell lines. Par3 loss in 
MDCK cells caused a multi-lumen phenotype similar to low-grade endometrial 
cancers. To understand what was causing an increase in proliferation in the 
MDCK cells without Par3, we examined a signaling pathway known to be 
affected by polarity proteins and regulated during menstruation, Notch 
signaling(81, 245). Par3, Ezrin, and Merlin knockdown in MDCK cells showed a 
decrease in Notch signaling downstream targets.  
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In addition, many endometrial cancer cell lines have low levels of Par3 
protein. When Par3 is expressed in these cell lines, proliferation and migration 
decreases, potentially in a PTEN-dependent manner. Since Notch signaling was 
downregulated in the MDCK cells depleted of Par3, we examined Notch 
downstream targets in the endometrial cancer cell lines. We found there was a 
trend of HES-1 increasing in the Par3 expressing cells compared with the 
parental control cells. In order to confirm that Notch signaling played a role in 
proliferation and migration, we utilized a g-secretase inhibitor and observed an 
increase in proliferation and migration, similar to parental cells treated with the 
inhibitor. This indicates that Notch signaling is involved in the changes in 
proliferation and migration. Interestingly, a Notch mutant mouse causes a similar 
phenotype as to what we observe in our Nf2seeKO and Nf2eeKO mice 
potentially showing that Notch is also important when polarity is disrupted in the 
endometrium(26). All together this data strongly suggests that polarity is 
necessary for proper membrane-bound Notch receptor signaling and tissue 
homeostasis in the endometrium; and the dysregulation of the Par complex early 
in endometrial cancers is involved in the progression of these tumors.  
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Chapter 6: Conclusions, Discussion, and Future Directions 
 
6.1 Conclusions and Discussion 
Apicobasal polarity is known to be necessary for the asymmetric division 
of a one-cell embryo and proper development and homeostasis of epithelial 
tissues(72, 124, 139). Polarity has been noted to change during implantation of a 
blastocyst, but otherwise has not been examined within the endometrium. The 
endometrium is a complex organ that goes through two different types of 
tubulogenesis: Mullerian duct formation and endometrial gland development. 
Recognizing how polarity is involved in the endometrium can help us understand 
infertility, uterine diseases, and proper endometrial development. This 
dissertation delves into how the uterus utilizes apicobasal polarity and the 
polarity regulator, Merlin, to properly develop and function. 
Merlin heterozygous female mice have a decreased litter size(219), 
however, before this dissertation it was not well understood why. We show that a 
conditional deletion of Merlin in the endometrium causes a loss of endometrial 
glands and disruption of apicobasal polarity on the luminal epithelium. The 
subfertility phenotype observed in Nf2-/+ female mice may be caused by a loss of 
heterzygosity within some regions of the endometrium, affecting the number of 
endometrial glands. The affect that Merlin has on endometrial glands is not 
completely unexpected since Merlin has been shown previously to be involved in 
renal tubule proliferation and hair follicle formation(225, 238).  
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The loss of Merlin in the endometrium both embryonically (Wnt7a-Cre) 
and postnatally (PR-Cre) caused the loss of endometrial glands indicating the 
loss of glands is not due to defects in Mullerian duct formation. Additionally, 
through the two conditional Merlin knockouts, we have shown that Merlin deletion 
in the epithelium specifically causes the aglandular phenotype. Endometrial 
gland loss was accompanied by loss of FoxA2 and Sox9 nuclear expression in a 
majority of the endometrial epithelium. While most cells did lose FoxA2 and Sox9 
there was a small subset of luminal epithelium that exhibited nuclear staining of 
these transcription factors. Muc1 staining also showed discrete areas that were 
similar in intensity to wild-type endometrial glands. Nf2seeKO (Nf2lox/lox; PR-Cre) 
mice are infertile, implying that the luminal epithelium that is positive for glandular 
markers may not fully function as glands. These results suggest that Merlin-
deficient luminal epithelium is able to turn on some glandular transcription factors 
but is unable to properly form glandular architecture or function as glands.  
If this is the case then we would expect proliferation, apoptosis, or cell 
movement/tension to change within the forming endometrial glands. Proliferation 
and apoptosis were examined to find minimal changes to the luminal epithelium 
at an early developmental stage suggesting that another area must be defective 
in gland formation. In order for the luminal epithelium to involute and form the 
glandular epithelium, changes in mechanical stress must occur allowing the 
initiation of the budding glandular structure. Tension markers were examined in 
Merlin-deficient tissue to show that an accumulation of Vinculin, Myosin IIB, and 
pMLC were observed at the basal membrane. Interestingly, the distribution of 
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cell:cell versus cell:extracellular matrix adhesion angles were also skewed 
between wild-type and Merlin-deficient tissue indicating disorganization of the 
luminal epithelium leading to stretching of the epithelial basal surface. We 
postulated that this change in basal membrane tension and angle distribution is 
related to the formation of a contractile actin ring at the apical lumen. When 
examined, we found a significant increase in intensity of the actin staining on the 
apical surface of the Merlin-deficient tissues. The increase in actin intensity was 
not only present at early stages like P7 but persisted and intensified by P21. 
Merlin is important in F-actin stabilization and loss of Merlin causes increased 
apical constriction in other epithelium(232, 319). This may indicate that the 
changes in transcription factors in the Merlin mutant could be caused by the 
increased apical constriction and changes in cellular tension. 
A recent study demonstrated that the Hippo and Wnt pathway are involved 
in the response a cell has to tension(284). Nuclear b-catenin increased with 
strain in mammalian cells in a cadherin-dependent manner(284). Wnt signaling is 
also necessary in endometrial gland development(35, 46). Since b-catenin 
staining looked similar between wild-type and Merlin-deficient tissue, we utilized 
qRT-PCR to examine mRNA expression of Wnt downstream targets. We 
determined that Myc, a Wnt signaling downstream target, was significantly 
decreased. There was also a slight decrease in Sox9 mRNA expression. 
However, Wnt signaling downstream targets can be regulated in a tissue specific 
fashion and other Wnt downstream targets like Axin2 and Cyclin D1 were 
upregulated in P7 tissue. Conditional loss of Merlin in other epithelium causes 
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changes to EGFR (Epidermal Growth Factor Receptor) internalization increasing 
the amount of EGFR signaling(232). Potentially the increase observed in Cyclin 
D1 is related to EGFR signaling since Cyclin D1 has also been observed 
downstream of the EGFR pathway(320). Interestingly, Sox17, a Wnt signaling 
negative regulator, was significantly higher in Nf2eeKO (Nf2lox/lox; Wnt7a-Cre) 
mice then wild-type mice at P7. This could indicate that Merlin regulates Wnt 
signaling through Sox17. Since Merlin and ERM proteins are known to regulate 
the apical junctions and the actin cytoskeleton, potentially the increased P-
cadherin levels in the mutant endometrium causes the increase in Sox17 
because other cadherins have been shown to affect the amount of Sox17 in the 
endoderm(283). Whether the changes to Wnt signaling or the changes to tension 
cause the aglandular phenotype observed in both Nf2eeKO and Nf2seeKO mice 
are not understood. However, unlike most Wnt signaling mouse mutants(4, 25, 
290), Nf2eeKO and Nf2seeKO have discrete patches of luminal epithelium that 
appear to function like wild-type glandular epithelium. This indicates that 
potentially Wnt signaling is secondary to the effects of tension and in fact the 
inability to form glandular architecture is due to changes in the cytoskeleton of 
the epithelium. 
Loss of Merlin also causes a loss of polarized endometrial epithelium. This 
loss of polarity may be what promotes the tension-mediated aglandular 
phenotype. Polarity has previously been shown to be important in proper 
tubulogenesis(321). Even more importantly, loss of polarity, specifically the Par 
complex can cause apical constriction in epithelium(322). In Drosophila, dPar3 
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(Bazooka) deletion caused apical constriction pulses to persist longer than wild-
type Drosophila(323). While in mammalian cell culture, loss of Par3 with 
mislocalization of aPKC caused an increase in ROCKs (Rho-associated kinases) 
mediated apical constriction(322). Thus the loss of Merlin causing mislocalization 
of Par3 and aPKC may cause the increased apical actin constriction and loss of 
gland formation(122).  
Since polarity is necessary for the proper implantation of a blastocyst in 
the female uterus, we can postulate that even if endometrial glands were able to 
form, Merlin-deficient females would have decreased fertility. In addition, there is 
not a significant change to YAP nuclear localization between wild-type and 
mutant tissue, suggesting this aglandular phenotype could be independent of 
Hippo signaling. Since Wnt signaling is known to be involved in gland formation 
and is affected in our Merlin-deficient mice, Wnt signaling could be critical for the 
loss of glands.  
The decrease in Wnt signaling in Nf2eeKO mice at P7 may be regulated 
by the role Merlin plays in cell junction maturation (Figure 3d). Since Merlin is 
necessary for the proper formation of adherens junctions, potentially the loss of 
Merlin causes an increase in the cytoplasmic pool of a-catenin. a-catenin has 
been shown to interact with APC and increase the propensity for b-catenin to be 
phosphorylated and degraded(51). With larger amounts of cytoplasmic a-catenin, 
there would be potentially more of an opportunity for APC to phosphorylate b-
catenin and in doing so decrease canonical Wnt signaling causing the 
downregulation of Myc and Sox9 observed.  
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While both Nf2eeKO and Nf2seeKO mice showed a similar phenotype, 
there were slight differences between Nf2eeKO and Nf2seeKO mice by P21. 
This could indicate that Merlin depletion in the stroma does cause an effect on 
the endometrium, however a stromal specific knockout of Merlin will better  
identify the individual roles of the epithelium and the stroma. One noted 
difference was that the myometrial density was more similar to wild-type mice in 
the Nf2seeKO mice than the Nf2eeKO mice (Figure 5o-p). In addition, Muc1 
staining was more intense in the Nf2eeKO luminal epithelium compared to the 
Nf2seeKO epithelium (Figure 5d-f). Interestingly, a subset of the Nf2eeKO mice, 
but not the Nf2seeKO mice, exhibit a dual endometrium phenotype (Figure 21a-
c). Since Wnt7a-Cre is expressed during Mullerian duct formation, this may be 
caused by a loss of polarized migration before PR-Cre is active, however this has 
not been examined in detail.  
While the majority of Nf2eeKO mice were unable to survive past 2 months 
(Figure 10a), Nf2seeKO were viable and we were able to perform a fecundity 
study to examine if they were fertile. The fecundity study showed that Nf2seeKO 
mice are infertile. Since the phenotype in the early Nf2eeKO and Nf2seeKO mice 
are similar, we postulate that Nf2eeKO mice are also infertile. It should be noted 
that the death of Nf2eeKO mice is not thought to be related to loss of Merlin in 
the uterus but rather one of the other tissues (lung, neurons, etc) that Merlin is 
deleted in the Nf2eeKO mice.  
Additionally, in the 4-month-old Nf2seeKO mice, we observed a gross 
morphology and histological change from wild-type mice. Some endometrial  
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Figure 21 Nf2eeKO mice has a double endometrium phenotype that Nf2seeKO 
mice do not.  
Wild-type (a) and Nf2eeKO (b) mice at P21 display a multi-lumen phenotype where 3 
mice out of 10 mice have a double endometrium (c).  
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epithelium was found to have vaginal markers (K14+) and the luminal epithelium 
was condensed to a small ovular lumen. This change in the lumen may be 
related to the increase in F-actin at the apical surface observed in younger 
female mice (P7 and P21). Interestingly, the Nf2seeKO uteri look very similar to a 
wild-type decidualized uterus between E3.5-E5.5(288). The phenotype appeared 
to worsen over time where the gross morphology of the uterus was drastically 
more inflamed by 5 months of age. This change in gross morphology between 
the wild-type and Nf2seeKO uteri were not observed in the few Nf2eeKO uteri we 
were able to obtain. The phenotype was also exacerbated if the female was 
mated. This implies that hormonal signaling may be related to the change in the 
uterine tissue. However, more work is needed to confirm this. Most mouse 
models that affect decidualization, cause a lack of a decidual reaction or an 
inability to remodel the tissue after decidualization. Thus, if this tissue is 
confirmed to be decidua, this would be one of the first mutants that acquires a 
decidual response without a stimulus. 
The 3-6 month old Nf2seeKO mouse also looks similar to a young female 
rat uterus in diestrus with a smaller ovular lumen(324). As female mice age, they 
eventually become acyclic(324, 325). One form of an acyclic uterus is persistent 
anestrus which also shows similarities to the small ovular luminal epithelium in 3-
6 month old Nf2seeKO mutants, though it is normally only seen after 14 months 
of age in mice(324, 325). Thus, Merlin loss in the mouse endometrium may be an 
accelerated aging phenotype not previously described well in mice. 
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While we were surprised that the Nf2seeKO mouse model did not develop 
cancer at 6 months of age, the mouse model did have a cell fate change and 
abnormal gross morphology of the uterus suggesting it may still develop cancer. 
There are multiple endometrial hyperplasia and cancer mouse models that do not 
show malignancies until 10-12 months of age(22, 326). Thus, potentially the 
Nf2seeKO mice need to age to at least 10 months in order for hyperplasia to be 
visible. In the E-cadherin null uterus endometrial cancer is also not observed 
except when they mutate p53 in addition to deleting E-cadherin(45). This may 
also be an indication that Nf2seeKO mice must accrue other driver mutations 
with Merlin to drive tumorigenesis. A similar phenotype is observed in a Par3 skin 
knockout model where an increase in tumorigenesis is only observed when a 
carcinogen is applied(137).  
Merlin is genetically altered in 5% of endometrial cancer cases(164, 165). 
Polarity genes including those regulated by Merlin are modified in 35% of 
endometrial cancer cases(164, 165).  Interestingly, Par3, a protein directly 
regulated by Merlin is mislocalized in low-grade endometrial tumors. We found 
another apical protein, Ezrin, was disrupted in low-grade endometrial cancer. 
Controversially, one paper determined that Ezrin was not expressed in normal 
endometrial glands and increased in endometrial cancer, however our work and 
others work refutes this(200, 202).  Since the formation of the apical junctions is 
necessary for proper apicobasal polarity establishment, we examined whether 
the apical junctions were also affected in low-grade endometrial cancer. Similar 
to the Nf2eeKO and Nf2seeKO mice, the adherens junction protein, E-cadherin, 
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still localizes properly in low-grade human endometrial cancer samples. This 
indicates adherens junctions are properly formed, however we were unable to tell 
whether the junctions are functional. Apicobasal polarity disruption without cell 
adhesion loss appears to be tissue specific, since it has been documented in 
many cancer cases that cell adhesion loss is linked to the disruption of 
apicobasal polarity. But our work and a few other labs have shown that cell 
adhesion may be maintained even when polarity is lost(72, 138, 327).  
Previous studies have shown that disruption of polarity proteins like Par3 
increase metastasis and late tumor progression(138), but our data indicates that 
polarity is lost in low-grade samples where metastasis is not common. This 
implies that polarity may be involved in tumor initiation or early tumor 
progression. In order to examine whether polarity actually contributes to early 
tumor formation or progression, we examined Par3 overexpression in 
endometrial cancer cells and Par3 knockdown in MDCK cells. We determined 
that Par3 regulates proliferation and migration in these cell lines through Notch 
signaling suggesting that Par3 is involved in tumor development.  
Notch signaling is known to be tumor suppressive and oncogenic in different 
tissues. We confirm that Notch signaling is tumor suppressive within the 
endometrium(72, 73). Utilizing a Notch signaling inhibitor, we establish that Notch 
signaling plays a role in Par3-regulated cell proliferation and migration in 
endometrial cancer cells. Based on Notch receptor localization data, we 
postulate polarity is critical for proper membrane partitioning of Notch receptors 
in the endometrium. This suggests that when polarity is lost, Notch receptors 
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mislocalize causing aberrant Notch activation since both the Notch receptor and 
ligand are membrane bound proteins. It may be noted that HES-1 was not 
comparably increased in the Par3 overexpression endometrial cancer cell lines 
as the decrease observed in Par3 knockdown MDCK cell lines. Both HEC-1-A 
and Ishikawa cells are not only from individual tumors but also have been in 
culture for more than a decade, invariably causing new mutations and expression 
changes. Potentially these cell lines required more than just Par3 expression to 
increase Notch signaling. In addition, we are unclear whether polarity loss can 
only facilitate cancer progression, in the presence of another mutation. 
PTEN is mutated in 50-80% of Type I ECs(71) and is known to be involved in 
cell polarity(130). In addition, PTEN has been shown to be lost in some tumors 
where it is not mutated(196). PTEN and AKT signaling are also linked to aberrant 
Notch signaling in prostate cancer(296, 328), so potentially there is a cooperation 
between PTEN, polarity and Notch signaling in EC. Moreover, when PTEN and 
polarity genes are genetically altered, there is a trend toward a decrease in 
cancer patients age and an increase in tumor invasion(164, 165). Thus, it is not 
unfeasible that PTEN may facilitate tumor progression and utilize polarity 
disruption to do so. Interestingly, in some endometrial cancer cell lines, those 
with PTEN and Par3 expression, caused the cells to form a bilayer or monolayer 
instead of a 4-5 multilayer cell sheet. These Par3 and PTEN expression cancer 
cell lines may be differentiating since in culture some differentiated mammalian 
epithelial cells form monolayers and localize ZO-1 to the apical junction.  
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Interestingly, PTEN, adhesion, and polarity proteins including Par3 have also 
been shown to have non-autonomous cell functions(246, 292, 329). This data 
along with the data from Chapter 5 implies that cell intrinsic changes in polarity, 
PTEN, and even adherens junction-mediated adhesion can be conveyed over a 
local area of the tissue (246, 292, 329). This is useful when looking at this 
research as a novel therapeutic approach. In fact, within the endometrial cancer 
cell line data, we noted that cells that had low to no Par3 present also exhibited 
decreases in proliferation and increases in tight junction protein localization. This 
indicates that if polarity is disrupted in a small subset of cells, there may be 
profound effect on the entire area, making it an interesting model for endometrial 
tumorigenesis. In addition, potentially finding a targeted approach to polarize a 
portion of the endometrial malignant epithelium may in fact help the entire 
endometrium, making this an ideal treatment strategy.  
 The Merlin-deficient mouse models and our endometrial cancer data both 
show a disruption of apicobasal polarity. In addition, Notch receptors increase 
membrane localization in Par3 expressing endometrial cancer cell lines. We 
postulated that the affect polarity has on Notch signaling is mediated through 
proper membrane compartmentalization of the Notch receptors. Notch mutant 
mice also cause an aglandular phenotype similar to the Merlin-deficient mice(26). 
In addition, both mice show increases in glandular marker, FoxA2, on the 
endometrial luminal epithelium(26). Merlin loss in the endometrium also causes 
downregulation of Wnt signaling. Wnt signaling has also been shown to be 
affected by the proper localization of the Wnt receptors (Frizzleds)(56). 
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Potentially, the conditional Merlin knockout mouse causes mislocalization of 
multiple membrane-bound receptors producing misregulation of different 
signaling pathways including Wnt and Notch leading to the aglandular phenotype 
observed.  
 
6.11 Overall Conclusions  
This work highlights the dynamic nature of endometrial tissue both during 
development and homeostasis. Moreover, it implies that the proper regulation of 
apicobasal polarity is necessary for normal development of endometrial glands  
and for correct endometrial reorganization. This dissertation provides evidence 
that Merlin plays a role in female fertility and potentially that Neurofibromatosis 
Type 2 patients should work with genetic counselors for infertility, however in-
human data is necessary to confirm this. In addition, this data alludes to a role for 
Merlin and apicobasal polarity within the aging of the endometrium and 
endometrial cancer (Figure 22). Figure 22 summarizes the findings of this 
dissertation. Overall this dissertation reveals novel results that may assist in 
future therapeutic approaches for female infertility and endometrial cancer. 
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Figure 22 Summary of Dissertation Findings 
A wild-type endometrium forms glands around Postnatal day 5 (P5) that are fully formed 
by P21 (a). In a Merlin-deficient endometrium, apicobasal polarity is disrupted. In 
addition, basal membrane tension and apical contractile actin, may cause an increase in 
Wnt signaling since Wnt is known to react to changes in tension (b). Additionally, since 
Merlin is known to regulate apical junction maturation, the decrease in Wnt signaling 
may be related to a large cytoplasmic a-catenin pool (b). a-catenin group b-catenin in 
the presence of APC leading to b-catenin degradation(51). When polarity is lost during 
endometrial homeostasis this causes a mislocalization of Notch receptors which leads to 
decreases of Notch signaling and increases in epithelial proliferation and migration (c).
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6.2 Future Directions 
The endometrial cancer work within this dissertation found that apicobasal 
polarity affects cell migration and proliferation through Notch signaling. However, it 
would be interesting to examine how Notch receptor overexpression and knockdown 
cell lines differed or were similar to the Par3 overexpression cell lines. It would also 
solidify the data to examine how an extracellular membrane mutation that causes 
mislocalization on the Notch receptor genes affects cell migration and proliferation. 
In order to understand whether there is cooperation between polarity and PTEN in 
endometrial cancer, we would like to examine PTEN overexpression and knockdown 
in the Par3 overexpression cancer cell lines. This will help us determine whether 
PTEN loss increases cell proliferation, migration, and differentiation.  
In addition, we would like to examine if Par3 affects the endometrial cancer cells, 
non-cell autonomously. In order to do this, we need to generate an inducible Par3 
overexpression cell line and co-culture them with parental cells to determine if the 
parental cells also show a decrease in proliferation and migration. Ideally, utilizing 
endometrial cancer mouse models, Par3 expression or Notch expression can be 
examined as a potential endometrial cancer therapeutic. Future studies examining 
how apicobasal polarity and/or downstream signaling pathways can be manipulated 
in dynamic tissues such as the endometrium could lead to better therapeutic 
strategies for patients with endometrial cancer. This work can improve the overall 
health of endometrial cancer patients and help with quality of life issues that 
survivors experience(330). 
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The mouse studies performed in this dissertation showed that Merlin is 
necessary for proper gland formation. Immunofluorescent stainings show that while 
neither YAP nuclear staining nor E-cadherin localization differs between wild-type 
and Merlin-deficient endometrial samples, Par3 localization does. This suggests that 
loss of apicobasal polarity is necessary for proper endometrial gland formation. A 
conditional Par3 knockout within the endometrium would confirm this. In addition, we 
would like to manipulate Mullerian duct development culturing techniques to 
examine endometrial gland development in real-time. These techniques can also be 
utilized to understand the double endometrium phenotype found in a subset of the 
Nf2eeKO mice (Figure 21a-c). We hypothesize this phenotype is related to polarized 
migration of the Mullerian duct and we can visualize Mullerian duct formation in real-
time to determine this.  
We can utilize a canonical Wnt signaling reporter mouse (TCF/Lef:H2B-GFP) to 
determine where Wnt signaling is increased or decreased within the uterus of the 
Nf2eeKO and Nf2seeKO mice(331). Due to some early data on expression of Sox9 
in the nuclei of Nf2eeKO and Nf2seeKO luminal epithelium, we are interested to also 
examine whether the tissue localization of active canonical Wnt signaling is affected 
in the early stages of endometrial gland development. Since it has been shown that 
Wnts are specifically active on the antimesometrial side of the uterus(24), we expect 
that Merlin may be important for correct localization of Wnt signaling.  
In order to determine whether a-catenin is involved in the decrease of Wnt 
signaling observed by qRT-PCR, we will examine a-catenin in vivo for changes in 
localization. Furthermore, we would like to understand the degree to which actin is 
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affected in the Nf2eeKO and Nf2seeKO uteri through both cell culture and potentially 
ex vivo studies of endometrial tissue. If we are able to create an ex vivo technique to 
culture postnatal tissue, we would like to assess the role of tension in endometrial 
gland development as well. To investigate tension, we would utilize blebbistatin, a 
myosin II inhibitor, to manipulate actomyosin tension and observe whether glands 
are able to form. 
In addition, the decidualization-like phenotype observed in Nf2seeKO mice needs 
to be further characterized and understood. First, to understand whether this is a 
decidualization phenotype, classification of the decidua is necessary. Confirmation 
that CD10 (membrane metalloendopeptidase), an endometrial stroma marker, is 
decreased and that BMP2 (Bone morphogenetic protein 2) increases will assist in 
this process(332). Furthermore, it has been shown that the makeup of immune cells 
present in decidua is different than endometrial stroma, specifically there is a 
decrease in T- and B-cells(333). Once we have confirmed this is in fact a 
spontaneous decidualization affect, we want to better understand the mechanism. 
We have hypothesized that since the mice do not begin to exhibit changes in the 
uteri until after puberty and it is exacerbated in multiparous females, hormones may 
be involved. In order to confirm this first, hormone levels need to be observed in 
wild-type versus Nf2seeKO mice. In addition, Nf2seeKO mice should have estradiol 
and/or progesterone injected to determine how that affects the uterine tissues. To 
determine whether this is a normal phenotype in aged female mice, we will examine 
older (1 year to 2 year) uteri for a similar uterus morphology. While we have time 
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points that span from day 7 to 6 months of age, potentially more time points between 
1 month to 4 months are necessary to understand when the phenotype is initiated.  
The question was broached of why we do not see tumor formation. To 
understand whether there will be a delayed tumor phenotype like other mutants, we 
should examine 12-month time points for potential malignant growths. In addition, 
PTEN and Merlin are genetically modified together in all except one EC case that 
Merlin is affected in(164, 165). Additionally, polarity and PTEN mutations together 
correlate with more invasive tumors then PTEN mutations alone(164, 165). In order 
to understand whether PTEN and Merlin work together in tumors, a PTENlox/lox; 
Nf2lox/lox; PR-Cre mouse has been generated. Work needs to be done to 
characterize whether endometrial cancer is present and if it is more invasive then 
PTENlox/lox; PR-Cre mice tumors. This dissertation brings to light a role of Merlin and 
apicobasal polarity in endometrial development and homeostasis that needs to be 
examined in more detail. 
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Chapter 6: Appendix 
Mouse Model/ 
Common Cre Name used Description Reference 
PR-Cre  
Progesterone Receptor (PR)- Cre: PR 
knockin that appears to start expressing 
within the Mullerian duct around 
postnatal day 1-5. Expression observed 
in the uterus, ovary, oviduct, mammary 
gland, and thymus (249) 
Wnt7a-Cre  
Wnt7a-Cre: A transgenic mouse line. A 
Wnt ligand expressed within the 
Mullerian duct epithelium at embryonic 
day 12.5. Wnt7a is also expressed 
within skin, lungs, limb bud formation, 
and neurogenesis.  (248) 
Ctnnb1lox/lox; PR-Cre  
Ctnnb1lox/lox: Lox/lox targeting exons 2-6 
of b-catenin gene.  
PR-Cre: previously described (pd) (46, 334)  
Wnt7alox/lox; PR-Cre  
Wnt7alox/lox: A Wnt ligand that in whole 
knockout mouse causes disruption of 
parameosnephric duct differentiation. 
Lox/lox targets exon 1 and 2 of the 
Wnt7a PR-Cre: pd (290) 
Wnt5alox/lox; PR-Cre  
Wnt5alox/lox:  A Wnt ligand that is thought 
to be primarily utilized in the non-
canonical planar cell polarity pathway. 
Lox/lox targted exons 2 and 3 of Wnt5a. 
PR-Cre pd (335, 336) 
Rosa26N1ICD/N1ICD; 
PR-Cre  
Rosa26N1ICD/N1ICD: Rosa26 promoter 
causes ubiquitous and constitute 
expression within mice. N1ICD amino 
acids 1749-2293  
PR-Cre:pd (26, 337) 
Rosa26N1ICD/N1ICD; 
Amhr2-Cre  
Rosa26N1ICD/N1ICD: pd 
Amhr2-Cre: The Anti-Mullerian 
Hormone Receptor Type 2 is necessary 
for the differentiation of male 
reproductive organs. It is expressed in 
the ovarian granulosa cells and in the 
female reproductive tract from 
embryonic day 12.5. It is specifically 
expressed within the myometrium and 
endometrial stroma.  Cre is knocked 
into the Amhr2 locus.  (338) 
Ctnnb1lox/lox; PR-Cre  
Ctnnb1lox/lox: Lox/lox targeting exons 2-6 
of b-catenin gene.  
PR-Cre: previously described (pd) (46, 334)  
 152 
Ctnnb1f(ex3)/+; PR-
Cre  
Ctnnb1f(ex3):  Lox/lox targeted the GSK-
3b phosphorylation site in the 3rd exon 
of b-catenin. This phosphorylation is 
necessary for degradation.   
PR-Cre:pd (46) 
Vangl2Lp/wt  
Vangl2Lp: Spontaneous point mutation 
in the Vangl2 gene that causes an 
amino acid change. The heterozygous 
mice are called Looptail mice and 
exhibited "looped" tails, harelip, cleft 
palate, etc. Homozygous mutation 
causes the neural tube to be completely 
open.  (339, 340) 
ScribCrc/wt  
ScribCrc: Circletail mice have a 
spontaneous mutation in scribble that 
causes craniorachischisis in 
homozygous mice. Heterozygous mice 
exhibit a kinked tail. (107) 
Dlg3Gt(P038A02)Wrst/Y  Gene trap vector utilized to mutate Dlg3 (341) 
Par3DE3/DE3  
Par3DE3/DE3: The exon 3 is deleted in the 
Partitioning defective 3 homolog (Par3) 
by flanking LoxP sites around exon 3 
with a CAG-Cre. (133) 
Par3lox/lox; K14-Cre Par3eKO 
Par3lox/lox: The Par3lox/lox allele utilized in 
the Par3DE3/DE3 mouse model. K14-Cre: 
the neo version had weak expression in 
the basal epidermis and hair follicles. 
Expression was stronger after birth in 
the basal epidermis and the hair 
follicles.  (137, 342) 
aPkcllox/lox; Nphs1-
Cre  
aPKCllox/lox:Lox/lox sites surrounding 
exon 5 of PKCl.  
Nphs1-Cre: Nphs1 promoter in a Cre 
transgene that expresses in the 
podocytes. 
(145, 343, 
344) 
aPkcllox/lox; K5-Cre  
aPKCllox/lox: pd.  
K5-Cre: A transgene containing the 
Keratin 5 promoter. K5 expression and 
deletion was observed in the basal 
epidermis and keratinocytes.  (345) 
Par6atm1.1(KOMP)Vlgcg/tm
1.1(KOMP)Vlcg  
Pard6atm1.1(KOMP)Vlcg: targeted mutation of 
Pard6a through a consortium (148) 
APCMin/+; PKCz-/-  
APC: a multiple intestinal neoplasia 
(Min) of the adenomatous polyposis coli 
(APC) gene.  
PKCz: deletion of PKCz by homologous 
recombination 
(140, 346, 
347) 
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Cdh1lox/lox; PR-Cre  
Cdh1lox/lox: E-cadherin gene with lox 
sites surrounding exons 6-10;  
PR-Cre: pd (45, 348) 
Tjp1lox/lox; Nphs1-Cre  
Tjp1lox/lox: Lox/lox sites flank exon 4 of 
the tight junction protein gene  (ZO-1). 
Nphs-1-Cre: pd (213) 
Cdh1tm1Cbm/tm1Cbm  
Cdh1tm1Cbm/tm1Cbm: E-cadherin gene with 
a portion of exon 7 and all of exon 8 
replaced by a neomycin insert. (218) 
Nf2lox/lox; Alb-Cre Nf2LKO 
Nf2lox/lox: Merlin gene with lox/lox sites 
flanking the 2nd exon.  
Alb-Cre: A transgenic mouse model 
with the liver-specific albuminin 
promoter 
(235, 255, 
286) 
Nf2lox/lox; Vil-Cre  
Nf2lox/lox:pd.  
Vil-Cre: Vilin promoter attached to a Cre 
showed expression of the Cre within the 
cortical renal tubule epithelia (349) 
Nf2lox/lox; K14-Cre Nf2skinKO Nf2lox/lox:pd. K14-Cre:pd   
Nf2lox/lox; Wnt7a-Cre Nf2eeKO Nf2lox/lox:pd. Wnt7a-Cre:pd   
Nf2lox/lox; PR-Cre Nf2seeKO Nf2lox/lox: pd. PR-Cre:pd   
TCF/Lef:H2B-GFP  
TCF/Lef:H2B-GFP: TA transgene 
containing the Wnt siganling responsive 
element, TCF/Lef was bound to 
H2B:GFP. Expression is observed 
when TCF/Lef are active (or Wnt 
signaling is on).  (331) 
PTENlox/lox; PR-Cre  
PTENlox/lox: Lox/lox sites flanking PTEN 
gene exon 5.  
PR-Cre pd (350) 
PTENlox/lox; Nf2lox/lox; 
PR-Cre  PTENlox/lox: pd. Nf2lox/lox: pd. PR-Cre: pd   
• Nefh-Cre 
• PO-Cre 
• P0-Sch-D(39-
121) 
• Mx1-Cre 
• Le-Cre 
• Vil-CreERT2 
Genes in 
Table 4 not 
described 
Nefh-Cre: A transgenic Cre with the 
neurofilament-H gene promoter. 
Expression is observed primarily in the 
cortex and hippocampal neurons. 
PO-Cre:A transgenic Cre with the rat P0 
gene. Expression is observed in 
Schwann cells. 
P0-Sch-D(39-121): A 62kD deletion 
mutant that is expressed in the 
peripheral nerves.  
Mx1-Cre: Mx1 promoter driving Cre-
recombinase in collecting duct epithelial 
cells and a subset of nephrons. Induced 
by IFN-a 
(225, 234, 
235, 351, 
352) 
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Le-Cre: The Le gene promoter is 
present on a transgene with Cre. 
Expression is initially observed at 
embryonic 9 in the lens placode and the 
eye lens. 
Vil-CreERT2:A tamoxifen inducible 
transgene with a Villin gene promoter 
bound to a Cre-Estrogen Receptor. 
Table 7 Mouse models discussed within the dissertation. 
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